Agriculture Biotechnology Market by Type of Organism (Plant, Animal, and Microbes), by Type, by Technology, and by Application - Global Forecast to 2030
The agriculture biotechnology market is estimated at USD 92.19 billion in 2025 and is projected to reach USD 144.25 billion by 2030, at a CAGR of 9.4%.
The growth of the agriculture biotechnology market is mainly driven by increasing global food demand, diminishing arable land, and the need for sustainable farming solutions. Biotechnology provides advanced methods to increase crop yields, improve soil health, and boost livestock productivity while reducing environmental impact. The rising use of genetically modified (GM) crops, microbial inoculants, and biofertilizers supports better resource management and less reliance on chemicals. Moreover, climate change pressures have sped up the adoption of drought-tolerant and pest-resistant crop varieties, ensuring greater resilience in farming. Governments and international groups are encouraging biotech innovations through supportive regulations, research funding, and sustainability efforts. Additionally, quick progress in genome editing, molecular diagnostics, and microbial engineering is broadening the use of agricultural biotechnology in plant, animal, and microbial systems. Collectively, these factors are driving a shift toward high-tech, eco-friendly, and high-yield agriculture worldwide.
“Plant biotechnology is projected to dominate the market during the forecast period.”
The plant biotechnology segment is expected to dominate the global agriculture biotechnology market during the forecast period. This leadership is due to widespread adoption of genetically modified (GM) crops, advancements in seed trait development, and increased use of biofertilizers and biopesticides. Rising global food demand, combined with the need for higher crop yields with limited natural resources, is fueling the adoption of plant biotechnology solutions. Farmers are increasingly opting for GM varieties that offer herbicide tolerance, pest resistance, and improved stress tolerance to achieve better yields and profits. Additionally, innovations in CRISPR and molecular breeding technologies are enhancing precision in crop improvement, enabling faster commercialization of new varieties. Supportive government policies promoting sustainable agriculture, along with public-private R&D investments, are further reinforcing this segment’s position. The growing need for climate-resilient and nutrient-rich crops will continue to make plant biotechnology a key driver of innovation in modern agriculture throughout the forecast period.
“The genetic engineering and genome editing subsegment is projected to dominate the agriculture biotechnology market during the forecast period.”
The genetic engineering and genome editing segment is expected to lead the agriculture biotechnology market during the forecast period due to its transformative effect on crop and livestock improvement. Technologies like CRISPR-Cas9, TALEN, and RNA interference (RNAi) are allowing scientists to create precise, high-yield varieties with better yield, stress tolerance, and nutritional content. An example is Calyxt’s gene-edited soybean, which produces healthier high-oleic oil and was among the first CRISPR-based crops to be commercialized in the US. Likewise, Corteva Agriscience has developed drought-tolerant maize using advanced gene-editing methods, greatly enhancing resilience in water-scarce areas.
In livestock, Genus PLC has developed pigs resistant to Porcine Reproductive and Respiratory Syndrome (PRRS), a breakthrough that enhances animal welfare and cuts economic losses. Governments in Brazil, the US, and Argentina have also relaxed regulations on gene-edited crops, supporting faster commercialization. Supported by strong R&D investments, global partnerships, and evolving biosafety frameworks, genetic engineering and genome editing are set to remain the leading technologies that drive efficiency, sustainability, and innovation in agricultural biotechnology through 2030.
“Asia Pacific is projected to be the fastest-growing market during the forecast period.”
The Asia Pacific region is expected to see the fastest growth in the agriculture biotechnology market during the forecast period, fueled by increasing food demands, expanding agricultural modernization, and government-supported initiatives that promote sustainable farming practices. Countries like China, India, Japan, and the Philippines are increasingly investing in biotechnology R&D to improve crop yields, livestock health, and soil fertility. The rising adoption of genetically modified (GM) crops, microbial biofertilizers, and bio-based pest control products is transforming the region’s agricultural landscape.
India’s approval of GM mustard (Dhara Mustard Hybrid-11) in 2023 and China’s increasing commercialization of gene-edited soybean and maize varieties highlight the region’s progressive regulatory approach. Additionally, strong support from regional organizations and public-private partnerships is driving innovation in genome editing, fermentation technologies, and microbial applications. With rapid population growth, limited arable land, and growing focus on food security, the Asia Pacific region is expected to remain the most dynamic and opportunity-rich area in the agriculture biotechnology market through 2030.
In-depth interviews were conducted with chief executive officers (CEOs), directors, and other executives from various key organizations in the agriculture biotechnology market.
Research Coverage
This research report categorizes the agriculture biotechnology market by organism type (plants, animals, microbes), type (genetic modification, crop protection, soil enhancement, stress tolerance, transgenic animals, vaccines, feed additives, diagnostics, biofertilizers, biocontrol agents, microbial enzymes & biostimulants, microbial genomics & fermentation), technology (genetic engineering, molecular diagnostics, tissue culture, CRISPR, fermentation, metagenomics, synthetic biology, and molecular marker-assisted selection), application (crop protection, yield enhancement, disease resistance, animal health management, soil health improvement, and sustainable nutrient cycling), end user (farmers and producer groups, agribusinesses, seed and input companies, research institutions, and government agencies), and region (North America, Europe, Asia Pacific, South America, the Middle East, and Africa).
The report’s scope includes detailed information about major factors such as drivers, restraints, challenges, and opportunities that influence the growth of agricultural biotechnology. A comprehensive analysis of key industry players offers insights into their businesses, services, key strategies, contracts, partnerships, agreements, product launches, mergers and acquisitions, and recent developments in the agriculture biotechnology market. This report also features a competitive analysis of emerging startups within the agriculture biotechnology ecosystem. Additionally, the study covers industry-specific trends such as technology analysis, ecosystem and market mapping, and patent and regulatory landscapes, among other topics.
Reasons to Buy This Report
The report will provide market leaders and new entrants with approximate revenue figures for the overall agriculture biotechnology sector and its subsegments. It will also help stakeholders understand the competitive landscape and gain insights to better position their businesses and develop effective go-to-market strategies. Additionally, the report helps stakeholders grasp the market pulse and offers information on key market drivers, restraints, challenges, and opportunities.
The report provides insights into the following points.
The growth of the agriculture biotechnology market is mainly driven by increasing global food demand, diminishing arable land, and the need for sustainable farming solutions. Biotechnology provides advanced methods to increase crop yields, improve soil health, and boost livestock productivity while reducing environmental impact. The rising use of genetically modified (GM) crops, microbial inoculants, and biofertilizers supports better resource management and less reliance on chemicals. Moreover, climate change pressures have sped up the adoption of drought-tolerant and pest-resistant crop varieties, ensuring greater resilience in farming. Governments and international groups are encouraging biotech innovations through supportive regulations, research funding, and sustainability efforts. Additionally, quick progress in genome editing, molecular diagnostics, and microbial engineering is broadening the use of agricultural biotechnology in plant, animal, and microbial systems. Collectively, these factors are driving a shift toward high-tech, eco-friendly, and high-yield agriculture worldwide.
“Plant biotechnology is projected to dominate the market during the forecast period.”
The plant biotechnology segment is expected to dominate the global agriculture biotechnology market during the forecast period. This leadership is due to widespread adoption of genetically modified (GM) crops, advancements in seed trait development, and increased use of biofertilizers and biopesticides. Rising global food demand, combined with the need for higher crop yields with limited natural resources, is fueling the adoption of plant biotechnology solutions. Farmers are increasingly opting for GM varieties that offer herbicide tolerance, pest resistance, and improved stress tolerance to achieve better yields and profits. Additionally, innovations in CRISPR and molecular breeding technologies are enhancing precision in crop improvement, enabling faster commercialization of new varieties. Supportive government policies promoting sustainable agriculture, along with public-private R&D investments, are further reinforcing this segment’s position. The growing need for climate-resilient and nutrient-rich crops will continue to make plant biotechnology a key driver of innovation in modern agriculture throughout the forecast period.
“The genetic engineering and genome editing subsegment is projected to dominate the agriculture biotechnology market during the forecast period.”
The genetic engineering and genome editing segment is expected to lead the agriculture biotechnology market during the forecast period due to its transformative effect on crop and livestock improvement. Technologies like CRISPR-Cas9, TALEN, and RNA interference (RNAi) are allowing scientists to create precise, high-yield varieties with better yield, stress tolerance, and nutritional content. An example is Calyxt’s gene-edited soybean, which produces healthier high-oleic oil and was among the first CRISPR-based crops to be commercialized in the US. Likewise, Corteva Agriscience has developed drought-tolerant maize using advanced gene-editing methods, greatly enhancing resilience in water-scarce areas.
In livestock, Genus PLC has developed pigs resistant to Porcine Reproductive and Respiratory Syndrome (PRRS), a breakthrough that enhances animal welfare and cuts economic losses. Governments in Brazil, the US, and Argentina have also relaxed regulations on gene-edited crops, supporting faster commercialization. Supported by strong R&D investments, global partnerships, and evolving biosafety frameworks, genetic engineering and genome editing are set to remain the leading technologies that drive efficiency, sustainability, and innovation in agricultural biotechnology through 2030.
“Asia Pacific is projected to be the fastest-growing market during the forecast period.”
The Asia Pacific region is expected to see the fastest growth in the agriculture biotechnology market during the forecast period, fueled by increasing food demands, expanding agricultural modernization, and government-supported initiatives that promote sustainable farming practices. Countries like China, India, Japan, and the Philippines are increasingly investing in biotechnology R&D to improve crop yields, livestock health, and soil fertility. The rising adoption of genetically modified (GM) crops, microbial biofertilizers, and bio-based pest control products is transforming the region’s agricultural landscape.
India’s approval of GM mustard (Dhara Mustard Hybrid-11) in 2023 and China’s increasing commercialization of gene-edited soybean and maize varieties highlight the region’s progressive regulatory approach. Additionally, strong support from regional organizations and public-private partnerships is driving innovation in genome editing, fermentation technologies, and microbial applications. With rapid population growth, limited arable land, and growing focus on food security, the Asia Pacific region is expected to remain the most dynamic and opportunity-rich area in the agriculture biotechnology market through 2030.
In-depth interviews were conducted with chief executive officers (CEOs), directors, and other executives from various key organizations in the agriculture biotechnology market.
- By Company Type: Tier 1–25%, Tier 2–45%, and Tier 3–30%
- By Designation: CXOs–20%, Managers–50%, Executives–30%
- By Region: North America–25%, Europe–20%, Asia Pacific–30%, South America–15%, and Rest of the World–10%
Research Coverage
This research report categorizes the agriculture biotechnology market by organism type (plants, animals, microbes), type (genetic modification, crop protection, soil enhancement, stress tolerance, transgenic animals, vaccines, feed additives, diagnostics, biofertilizers, biocontrol agents, microbial enzymes & biostimulants, microbial genomics & fermentation), technology (genetic engineering, molecular diagnostics, tissue culture, CRISPR, fermentation, metagenomics, synthetic biology, and molecular marker-assisted selection), application (crop protection, yield enhancement, disease resistance, animal health management, soil health improvement, and sustainable nutrient cycling), end user (farmers and producer groups, agribusinesses, seed and input companies, research institutions, and government agencies), and region (North America, Europe, Asia Pacific, South America, the Middle East, and Africa).
The report’s scope includes detailed information about major factors such as drivers, restraints, challenges, and opportunities that influence the growth of agricultural biotechnology. A comprehensive analysis of key industry players offers insights into their businesses, services, key strategies, contracts, partnerships, agreements, product launches, mergers and acquisitions, and recent developments in the agriculture biotechnology market. This report also features a competitive analysis of emerging startups within the agriculture biotechnology ecosystem. Additionally, the study covers industry-specific trends such as technology analysis, ecosystem and market mapping, and patent and regulatory landscapes, among other topics.
Reasons to Buy This Report
The report will provide market leaders and new entrants with approximate revenue figures for the overall agriculture biotechnology sector and its subsegments. It will also help stakeholders understand the competitive landscape and gain insights to better position their businesses and develop effective go-to-market strategies. Additionally, the report helps stakeholders grasp the market pulse and offers information on key market drivers, restraints, challenges, and opportunities.
The report provides insights into the following points.
- Analysis of key drivers (growing demand for sustainable and high-yield biotechnology-based agriculture), restraints (high regulatory hurdles and lengthy approval processes for GMOs), opportunities (increasing adoption of microbial and bio-based agricultural inputs globally), and challenges (public skepticism and ethical concerns over genetic modification technologies) influencing the growth of the agriculture biotechnology market
- Product Development/Innovation: Detailed insights into ongoing R&D initiatives in genome editing, CRISPR applications, microbial biofertilizers, and biocontrol agents are included, along with emerging product launches across plant, animal, and microbial biotechnology segments.
- Market Development: The report offers comprehensive information about expanding market opportunities across developed and emerging regions, emphasizing growing investment in biotechnology-enabled agriculture.
- Market Diversification: Includes detailed analysis of new product innovations, regional adoption patterns, government-funded biotechnology initiatives, and expansion of key players into new applications such as climate-resilient crops and animal health solutions.
- Competitive Assessment: In-depth assessment of market share, company strategies, product portfolios, and innovation footprints of leading players such as Bayer AG (Germany), Corteva Agriscience (US), BASF SE (Germany), Syngenta AG (Switzerland), Novonesis (Denmark), Ginkgo Bioworks (US), Zoetis Inc. (US), and ADM Animal Nutrition (US), among others in the agriculture biotechnology ecosystem.
1 INTRODUCTION
1.1 STUDY OBJECTIVES
1.2 MARKET DEFINITION
1.3 STUDY SCOPE
1.3.1 MARKET SEGMENTATION AND REGIONS COVERED
1.3.2 INCLUSIONS AND EXCLUSIONS
1.3.3 YEARS CONSIDERED
1.4 UNITS CONSIDERED
1.4.1 CURRENCY CONSIDERED
1.5 STAKEHOLDERS
2 RESEARCH METHODOLOGY
2.1 RESEARCH DATA
2.1.1 SECONDARY DATA
2.1.1.1 Key data from secondary sources
2.1.2 PRIMARY DATA
2.1.2.1 Key data from primary sources
2.1.2.2 Key primary participants
2.1.2.2.1 AGRICULTURE BIOTECHNOLOGY COMPANIES
2.1.2.3 Breakdown of primary interviews
2.1.2.4 Key industry insights
2.2 MARKET SIZE ESTIMATION
2.2.1 BOTTOM-UP APPROACH
2.2.2 TOP-DOWN APPROACH
2.3 DATA TRIANGULATION
2.4 FACTOR ANALYSIS
2.5 RESEARCH ASSUMPTIONS
2.6 RESEARCH LIMITATIONS
3 EXECUTIVE SUMMARY
4 PREMIUM INSIGHTS
4.1 AGRICULTURE BIOTECHNOLOGY MARKET OVERVIEW
4.2 AGRICULTURE BIOTECHNOLOGY MARKET: GROWTH RATES OF MAJOR REGIONAL SUBMARKETS
4.3 EUROPE: AGRICULTURE BIOTECHNOLOGY MARKET FOR PLANT BIOTECHNOLOGY, BY TYPE AND COUNTRY
4.4 AGRICULTURE BIOTECHNOLOGY MARKET, BY ORGANISM TYPE AND REGION
4.5 MICROBIAL BIOTECHNOLOGY MARKET, BY TECHNOLOGY
4.6 ANIMAL BIOTECHNOLOGY MARKET, BY APPLICATION
4.7 PLANT BIOTECHNOLOGY MARKET, BY APPLICATION
5 MARKET OVERVIEW
5.1 INTRODUCTION
5.2 MARKET DYNAMICS
5.2.1 DRIVERS
5.2.1.1 Growing Need for Sustainable Food Production
5.2.1.2 Government Support and Regulatory Approvals
5.2.1.3 Rising Focus on Reducing Chemical Inputs
5.2.2 RESTRAINTS
5.2.2.1 Public Perception and Ethical Concerns
5.2.2.2 Infrastructure and Cold Chain Limitations
5.2.3 OPPORTUNITIES
5.2.3.1 Expansion in Emerging Economies
5.2.3.2 Focus on Carbon-negative and Regenerative Agriculture
5.2.3.3 Growth in Microbial and Bio-based Inputs
5.2.4 CHALLENGES
5.2.4.1 Regulatory Uncertainty and Trade Barriers
5.2.4.2 Dominance of Few Multinational Players
5.2.4.3 Climate and Disease Variability
5.3 IMPACT OF GEN AI ON AGRICULTURE BIOTECHNOLOGY
5.3.1 INTRODUCTION
5.3.2 USE OF GEN AI IN AGRICULTURE BIOTECHNOLOGY
5.3.3 CASE STUDY ANALYSIS
5.3.3.1 Using Gen AI to Enhance Crop Disease Diagnostics via Synthetic Imagery
5.3.3.2 PhytoSynth: Generative AI for Crop Disease Data Generation
5.3.4 IMPACT ON AGRICULTURE BIOTECHNOLOGY MARKET
5.3.5 ADJACENT ECOSYSTEM WORKING ON GEN AI
6 INDUSTRY TRENDS
6.1 INTRODUCTION
6.2 PORTER’S FIVE FORCES ANALYSIS
6.2.1 INTENSITY OF COMPETITIVE RIVALRY
6.2.2 BARGAINING POWER OF SUPPLIERS
6.2.3 BARGAINING POWER OF BUYERS
6.2.4 THREAT OF SUBSTITUTES
6.2.5 THREAT OF NEW ENTRANTS
6.3 MACROECONOMIC INDICATORS
6.3.1 GLOBAL POPULATION GROWTH & FOOD DEMAND
6.3.2 STABLE GLOBAL GDP GROWTH AND MACRO PROJECTIONS
6.4 SUPPLY CHAIN ANALYSIS
6.5 VALUE CHAIN ANALYSIS
6.6 ECOSYSTEM ANALYSIS
6.6.1 DEMAND SIDE
6.6.2 SUPPLY SIDE
6.7 INDICATIVE PRICING ANALYSIS
6.7.1 INDICATIVE PRICING ANALYSIS, BY KEY COMPANY AND ORGANISM
6.7.2 INDICATIVE PRICING BY REGION
6.8 TRADE ANALYSIS
6.8.1 TRADE ANALYSIS OF HS CODE 843280: PREPARED CULTURE MEDIA FOR DEVELOPMENT OR MAINTENANCE OF MICROORGANISMS, INCLUDING VIRUSES AND THE LIKE, OR OF PLANT, HUMAN, OR ANIMAL CELLS
6.8.1.1 Export Trends of Agriculture Biotechnology under HS Code 382100 (2020–2024)
6.8.1.2 Import Trends of Agriculture Biotechnology under HS Code 382100 (2020–2024)
6.9 KEY CONFERENCES & EVENTS
6.10 TRENDS IMPACTING CUSTOMERS’ BUSINESSES
6.11 INVESTMENT AND FUNDING SCENARIO
6.12 CASE STUDY ANALYSIS
6.12.1 PIVOT BIO’S GENE-EDITED NITROGEN-FIXING MICROBES (2025)
6.12.2 NOVONESIS MICROBIAL SEED INOCULANT (JUMPSTART®) (2024)
6.12.3 RECOMBINETICS — GENE-EDITED LIVESTOCK FOR DISEASE RESISTANCE AND WELFARE ENHANCEMENT (2024)
6.13 IMPACT OF 2025 US TARIFF - AGRICULTURE BIOTECHNOLOGY MARKET
6.13.1 INTRODUCTION
6.13.2 KEY TARIFF RATES
6.13.3 PRICE IMPACT ANALYSIS
6.13.4 IMPACT ON COUNTRY/REGION
6.13.4.1 United States
6.13.4.2 European Union
6.13.4.3 China
6.13.5 IMPACT ON END-USE INDUSTRIES
7 CUSTOMER LANDSCAPE & BUYER BEHAVIOR
7.1 INTRODUCTION
7.2 DECISION-MAKING PROCESS
7.3 BUYER STAKEHOLDERS AND BUYING EVALUATION CRITERIA
7.3.1 KEY STAKEHOLDERS IN BUYING PROCESS
7.3.2 BUYING CRITERIA
7.4 ADOPTION BARRIERS & INTERNAL CHALLENGES
7.5 UNMET NEEDS FROM VARIOUS END-USE INDUSTRIES
7.6 MARKET PROFITABILITY
8 STRATEGIC DISRUPTION THROUGH TECHNOLOGY, PATENTS, DIGITAL, AND AI ADOPTION
8.1 INTRODUCTION
8.2 KEY EMERGING TECHNOLOGIES
8.3 COMPLEMENTARY TECHNOLOGIES
8.4 TECHNOLOGY/PRODUCT ROADMAP
8.5 PATENT ANALYSIS
8.5.1 LIST OF MAJOR PATENTS
8.6 FUTURE APPLICATIONS
8.7 IMPACT OF AI/GEN AI ON AGRICULTURE BIOTECHNOLOGY MARKET
8.7.1 TOP USE CASES AND MARKET POTENTIAL
8.7.1.1 AI Use Cases in Agriculture Biotechnology Market
8.7.1.1.1 AI-driven Genomic Selection and Trait Discovery
8.7.1.1.2 Precision Bio-input Design and Microbial Optimization
8.7.1.1.3 Market Potential Impact of AI in Agricultural Biotechnology
8.7.1.1.4 Acceleration of R&D and Commercialization Pipelines
8.7.1.1.5 Enabling Data-driven Sustainable Agriculture and Global Scalability
8.7.2 BEST PRACTICES IN AGRICULTURE BIOTECHNOLOGY PROCESSING
8.7.3 CASE STUDIES OF AI IMPLEMENTATION IN AGRICULTURE BIOTECHNOLOGY MARKET
8.7.3.1 Using Gen AI to Enhance Crop Disease Diagnostics via Synthetic Imagery
8.7.3.2 PhytoSynth: Generative AI for Crop Disease Data Generation
8.7.4 INTERCONNECTED & ADJACENT ECOSYSTEMS AND IMPACT ON MARKET PLAYERS
8.7.5 CLIENTS’ READINESS TO ADOPT GENERATIVE AI IN AGRICULTURE BIOTECHNOLOGY MARKET
8.8 SUCCESS STORIES AND REAL-WORLD APPLICATIONS
9 SUSTAINABILITY AND REGULATORY LANDSCAPE
9.1 INTRODUCTION
9.2 REGIONAL REGULATIONS AND COMPLIANCE
9.2.1 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
9.2.2 INDUSTRY STANDARDS
9.3 SUSTAINABILITY INITIATIVES
9.3.1 CARBON IMPACT AND ECO-APPLICATIONS OF AGRICULTURE BIOTECHNOLOGY
9.4 SUSTAINABILITY IMPACT AND REGULATORY POLICY INITIATIVES
9.5 CERTIFICATIONS, LABELING, ECO-STANDARDS
10 AGRICULTURE BIOTECHNOLOGY MARKET, BY TYPE OF ORGANISM
10.1 INTRODUCTION
10.2 PLANTS
10.2.1 GROWING GLOBAL FOOD DEMAND, CLIMATE CHANGE RESILIENCE, AND SUSTAINABILITY GOALS ACCELERATING ADOPTION OF PLANT BIOTECHNOLOGY
10.3 ANIMALS
10.3.1 RISING PROTEIN DEMAND, DISEASE PREVENTION NEEDS, AND SUSTAINABLE LIVESTOCK PRODUCTION DRIVING ANIMAL BIOTECHNOLOGY ADVANCEMENTS
10.4 MICROBIALS
10.4.1 RISING DEMAND FOR SUSTAINABLE SOIL HEALTH, BIOFERTILIZERS, AND ECO-FRIENDLY PEST CONTROL DRIVES MICROBIAL BIOTECHNOLOGY GROWTH
11 AGRICULTURE BIOTECHNOLOGY MARKET, BY TYPE
11.1 INTRODUCTION
11.2 PLANT BIOTECHNOLOGY MARKET, BY TYPE
11.2.1 GROWING FOCUS ON ENHANCING CROP YIELD, STRESS RESISTANCE, AND SUSTAINABILITY
11.2.2 GENETIC MODIFICATION
11.2.2.1 Crop protection (Biopesticides, Herbicide-tolerant Traits)
11.2.2.1.1 Rising pest resistance, yield loss, and sustainability goals drive innovation in biotechnology-based crop protection
11.2.2.2 Soil enhancement (Biofertilizers, Microbial Solutions)
11.2.2.2.1 Declining soil fertility and sustainable farming practices are driving demand for biotechnology-based soil enhancement solutions
11.2.2.3 Stress tolerance (Drought/Heat-resistant Crops)
11.2.2.3.1 Climate change, erratic weather, and yield instability are driving demand for stress-tolerant biotechnology crops
11.2.2.4 Animal biotechnology market, by type
11.2.2.4.1 Focus on improving livestock productivity, health, and genetic performance
11.2.3 TRANSGENIC ANIMALS
11.2.3.1 Animal vaccine development
11.2.3.1.1 Increasing livestock diseases and zoonotic threats drive demand for advanced biotechnology-based animal vaccine solutions
11.2.3.2 Feed additives & nutrient optimization
11.2.3.2.1 Rising demand for efficient, sustainable livestock production drives adoption of biotechnology-based feed additives globally
11.2.3.3 Animal health diagnostics
11.2.3.3.1 Growing disease incidence and need for early detection drive innovation in biotechnology-based animal diagnostics
11.2.3.4 Microbial biotechnology market, by type
11.2.3.4.1 Expanding use of microbes in agriculture enhances yield and sustainability
11.2.4 MICROBIAL BIOFERTILIZERS
11.2.4.1 Biocontrol agents (Fungi, Bacteria)
11.2.4.1.1 Stringent pesticide regulations and growing demand for residue-free, sustainable crop protection accelerate biocontrol adoption globally
11.2.4.2 Microbial enzymes & biostimulants
11.2.4.2.1 Rising demand for eco-friendly, stress-resilient crop enhancement solutions drives microbial enzyme and biostimulant adoption globally
11.2.4.3 Microbial genomics & fermentation
11.2.4.3.1 Advancements in microbial genomics and precision fermentation enable high-efficiency, scalable bio-based agricultural innovations globally
12 AGRICULTURE BIOTECHNOLOGY MARKET, BY APPLICATION
12.1 INTRODUCTION
12.2 PLANT BIOTECHNOLOGY MARKET, BY APPLICATION
12.2.1 CROP PROTECTION
12.2.1.1 Increasing pest resistance and need for sustainable pest control drive innovation in biotech crop protection
12.2.2 YIELD ENHANCEMENT
12.2.2.1 Rising food demand and limited arable land accelerate adoption of high-yield biotechnology-based crop systems
12.2.3 NUTRITIONAL QUALITY IMPROVEMENT
12.2.3.1 Rising focus on combating micronutrient deficiency fuels demand for biotechnology-based nutritional crop improvement
12.2.4 CLIMATE-RESILIENT CROPS
12.2.4.1 Intensifying climate variability and food security concerns drive investment in biotechnology-based resilient crop development
12.3 ANIMAL BIOTECHNOLOGY MARKET, BY APPLICATION
12.3.1 DISEASE RESISTANCE
12.3.1.1 Rising livestock disease outbreaks and antibiotic resistance drive adoption of genetic and molecular resistance solutions
12.3.2 GROWTH & PRODUCTIVITY ENHANCEMENT
12.3.2.1 Increasing protein demand and emission-reduction mandates promote biotechnology adoption for livestock growth and productivity enhancement
12.3.3 ANIMAL WELFARE SOLUTIONS
12.3.3.1 Rising ethical concerns and regulatory focus on humane production drive demand for biotechnology-enabled animal welfare systems
12.3.4 VETERINARY THERAPEUTICS
12.3.4.1 Growing prevalence of zoonotic diseases and advancements in biologics fuel growth of veterinary biotechnology therapeutics
12.4 MICROBIAL BIOTECHNOLOGY MARKET, BY APPLICATION
12.4.1 SOIL HEALTH MANAGEMENT
12.4.1.1 Increasing focus on regenerative agriculture and soil restoration drives adoption of microbial soil health management technologies
12.4.2 PEST & DISEASE CONTROL
12.4.2.1 Rising pesticide restrictions and demand for organic produce drive adoption of microbial pest control solutions
12.4.3 SUSTAINABLE NUTRIENT CYCLING
12.4.3.1 Growing nutrient inefficiency and fertilizer price volatility accelerate adoption of microbial nutrient cycling technologies
12.4.4 BIOREMEDIATION & WASTE UTILIZATION
12.4.4.1 Rising agricultural waste generation and environmental pollution drive adoption of microbial bioremediation technologies
13 AGRICULTURE BIOTECHNOLOGY MARKET, BY TECHNOLOGY
13.1 INTRODUCTION
13.2 PLANT BIOTECHNOLOGY MARKET, BY TECHNOLOGY
13.2.1 TISSUE CULTURE
13.2.1.1 Growing need for disease-free, high-quality planting materials and export-grade crops accelerates tissue culture adoption globally
13.2.2 SOMATIC HYBRIDIZATION
13.2.2.1 Advancements in cell fusion and interspecies hybridization foster innovation in developing resilient and high-yield crop hybrids
13.2.3 MOLECULAR DIAGNOSTICS
13.2.3.1 Increasing global biosecurity regulations and focus on disease-free seed trade enhance molecular diagnostic adoption in agriculture
13.2.4 GENETIC ENGINEERING
13.2.4.1 Genetic engineering represents most transformative technology in modern plant biotechnology
13.3 ANIMAL BIOTECHNOLOGY MARKET, BY TECHNOLOGY
13.3.1 EMBRYO RESCUE & TRANSFER
13.3.1.1 Growing demand for genetic improvement, reproductive efficiency, and conservation drives widespread adoption of embryo transfer technologies
13.3.2 GENETIC ENGINEERING & CRISPR
13.3.2.1 Expanding use of CRISPR-Cas9 in livestock breeding drives precision genetic improvement and sustainability in animal farming
13.3.3 MOLECULAR DIAGNOSTICS
13.3.3.1 Rising livestock disease incidence and demand for rapid, accurate pathogen detection bolster molecular diagnostic adoption globally
13.3.4 VACCINE BIOTECHNOLOGIES
13.3.4.1 Rising zoonotic disease threats and focus on antibiotic-free livestock production accelerate biotech vaccine innovations globally
13.4 MICROBIAL BIOTECHNOLOGY MARKET, BY TECHNOLOGY
13.4.1 FERMENTATION TECHNOLOGY
13.4.1.1 Increasing use of sustainable biofertilizers and precision fermentation drives growth in microbial input production technologies
13.4.2 METAGENOMICS & MICROBIAL GENOMICS
13.4.2.1 Expanding soil microbiome research and AI-based genomic analysis accelerate innovation in precision microbial biotechnology
13.4.3 MOLECULAR MARKER-ASSISTED SELECTION
13.4.3.1 Rising need for efficient microbial strain identification promotes adoption of molecular marker-assisted selection technologies
13.4.4 SYNTHETIC BIOLOGY
13.4.4.1 Expanding investments in engineered microbes and metabolic design accelerate adoption of synthetic biology in agriculture and biotechnology
14 AGRICULTURE BIOTECHNOLOGY MARKET, BY REGION
14.1 INTRODUCTION
14.2 NORTH AMERICA
14.2.1 US
14.2.1.1 Expanding bioengineering investments, AI-integrated field trials, and streamlined GMO regulations drive US biotechnology market leadership
14.2.2 CANADA
14.2.2.1 Supportive biosafety regulations and strong genomic research collaborations boost biotechnology advancement and sustainability in Canada
14.2.3 MEXICO
14.2.3.1 Expanding gene-editing research and sustainable agriculture policies accelerate biotechnology adoption and innovation in Mexico
14.3 EUROPE
14.3.1 GERMANY
14.3.1.1 Strong federal R&D support and industrial-scale bio-innovation reinforce Germany’s leadership in sustainable agricultural biotechnology
14.3.2 ITALY
14.3.2.1 Expanding bioinput research programs and regional sustainability initiatives accelerate biotechnology adoption in Italy’s agri-sector
14.3.3 FRANCE
14.3.3.1 Strong government R&D investment and progressive biosafety policies enhance France’s leadership in sustainable agricultural biotechnology
14.3.4 SPAIN
14.3.4.1 Expanding gene-editing research and strong government funding boost Spain’s sustainable agricultural biotechnology development
14.3.5 UK
14.3.5.1 Regulatory reforms and strong R&D investments strengthen UK’s leadership in precision agricultural biotechnology innovation
14.3.6 REST OF EUROPE
14.4 ASIA PACIFIC
14.4.1 CHINA
14.4.1.1 Expanding GMO approvals and strong state-led R&D investments reinforce China’s leadership in agricultural biotechnology innovation
14.4.2 INDIA
14.4.2.1 Government-led biotech missions and microbial innovation drive India’s agricultural transformation toward sustainable productivity growth
14.4.3 JAPAN
14.4.3.1 Strong government funding and innovation-driven industry partnerships accelerate Japan’s agricultural biotechnology advancement
14.4.4 AUSTRALIA & NEW ZEALAND
14.4.4.1 Progressive gene-editing reforms and climate-resilient R&D accelerate biotechnology growth in Australia and New Zealand
14.4.5 REST OF ASIA PACIFIC
14.5 SOUTH AMERICA
14.5.1 BRAZIL
14.5.1.1 Expanding GMO approvals and microbial innovation solidify Brazil’s leadership in agricultural biotechnology development
14.5.2 ARGENTINA
14.5.2.1 Global leadership in GM wheat and microbial bioinputs strengthens Argentina’s agricultural biotechnology innovation capacity
14.5.3 REST OF SOUTH AMERICA
14.6 REST OF THE WORLD
14.6.1 MIDDLE EAST
14.6.1.1 Government-backed innovation and food security strategies drive biotechnology adoption across Middle East’s arid regions
14.6.2 AFRICA
14.6.2.1 Expanding GM approvals and microbial innovation strengthen Africa’s resilience in sustainable agricultural biotechnology adoption
15 COMPETITIVE LANDSCAPE
15.1 OVERVIEW
15.2 KEY PLAYERS’ STRATEGIES, 2022–2024
15.3 REVENUE ANALYSIS, 2022–2024
15.4 MARKET SHARE ANALYSIS, 2024
15.5 BRAND/PRODUCT COMPARISON
15.5.1 BAYER AG (GERMANY)
15.5.2 SYNGENTA AG (SWITZERLAND)
15.5.3 CORTEVA (US)
15.5.4 ZOETIS INC. (US)
15.5.5 NOVONESIS GROUP (DENMARK)
15.6 COMPANY VALUATION AND FINANCIAL METRICS
15.6.1 COMPANY VALUATION
15.6.2 EV/EBITDA
15.7 PLANT BIOTECHNOLOGY COMPANY EVALUATION MATRIX: KEY PLAYERS, 2024
15.7.1 STARS
15.7.2 EMERGING LEADERS
15.7.3 PERVASIVE PLAYERS
15.7.4 PARTICIPANTS
15.7.5 COMPANY FOOTPRINT: KEY PLAYERS, 2024
15.7.5.1 Company footprint
15.7.5.2 Region footprint
15.7.5.3 Type footprint
15.7.5.4 Application footprint
15.8 ANIMAL BIOTECHNOLOGY COMPANY EVALUATION MATRIX: KEY PLAYERS, 2024
15.8.1 STARS
15.8.2 EMERGING LEADERS
15.8.3 PERVASIVE PLAYERS
15.8.4 PARTICIPANTS
15.8.5 COMPANY FOOTPRINT: KEY PLAYERS, 2024
15.8.5.1 Company footprint
15.8.5.2 Region footprint
15.8.5.3 Type footprint
15.8.5.4 Application footprint
15.9 MICROBIAL BIOTECHNOLOGY COMPANY EVALUATION MATRIX: KEY PLAYERS, 2024
15.9.1 STARS
15.9.2 EMERGING LEADERS
15.9.3 PERVASIVE PLAYERS
15.9.4 PARTICIPANTS
15.9.5 COMPANY FOOTPRINT: KEY PLAYERS, 2024
15.9.5.1 Company footprint
15.9.5.2 Region footprint
15.9.5.3 Type footprint
15.9.5.4 Application footprint
15.10 COMPETITIVE SCENARIO
15.10.1 PRODUCT LAUNCHES
15.10.2 DEALS
15.10.3 EXPANSIONS
16 COMPANY PROFILES
16.1 PLANT BIOTECHNOLOGY COMPANIES
16.1.1 BASF SE
16.1.1.1 Business overview
16.1.1.2 Products/Solutions/Services offered
16.1.1.3 Recent developments
16.1.1.3.1 Product launches
16.1.1.3.2 Deals
16.1.1.3.3 Expansions
16.1.1.4 MnM view
16.1.1.4.1 Key strengths
16.1.1.4.2 Strategic choices
16.1.1.4.3 Weaknesses and competitive threats
16.1.2 BAYER AG
16.1.2.1 Business overview
16.1.2.2 Products/Solutions/Services offered
16.1.2.3 Recent developments
16.1.2.3.1 Product launches
16.1.2.3.2 Deals
16.1.2.3.3 Expansions
16.1.2.4 MnM view
16.1.2.4.1 Key strengths
16.1.2.4.2 Strategic choices
16.1.2.4.3 Weaknesses and competitive threats
16.1.3 CORTEVA AGRISCIENCE
16.1.3.1 Business overview
16.1.3.2 Products/Solutions/Services offered
16.1.3.3 Recent developments
16.1.3.3.1 Product launches
16.1.3.3.2 Deals
16.1.3.4 MnM view
16.1.3.4.1 Key strengths
16.1.3.4.2 Strategic choices
16.1.3.4.3 Weaknesses and competitive threats
16.1.4 SYNGENTA
16.1.4.1 Business overview
16.1.4.2 Products/Solutions/Services offered
16.1.4.3 Recent developments
16.1.4.3.1 Product launches
16.1.4.3.2 Deals
16.1.4.3.3 Expansions
16.1.4.4 MnM view
16.1.4.4.1 Key strengths
16.1.4.4.2 Strategic choices
16.1.4.4.3 Weaknesses and competitive threats
16.1.5 KWS SAAT SE & CO. KGAA
16.1.5.1 Business overview
16.1.5.2 Products/Solutions/Services offered
16.1.5.3 Recent developments
16.1.5.3.1 Product launches
16.1.5.3.2 Deals
16.1.5.3.3 Other developments
16.1.5.4 MnM view
16.1.5.4.1 Key strengths
16.1.5.4.2 Strategic choices
16.1.5.4.3 Weaknesses and competitive threats
16.1.6 UPL
16.1.6.1 Business overview
16.1.6.2 Products/Solutions/Services offered
16.1.6.3 Recent developments
16.1.6.3.1 Product launches
16.1.6.3.2 Deals
16.1.6.4 MnM view
16.1.6.4.1 Key strengths
16.1.6.4.2 Strategic choices
16.1.6.4.3 Weaknesses and competitive threats
16.1.7 FMC CORPORATION
16.1.7.1 Business overview
16.1.7.2 Products/Solutions/Services offered
16.1.7.3 Recent developments
16.1.7.3.1 Product launches
16.1.7.3.2 Deals
16.1.7.3.3 Expansions
16.1.7.3.4 Other developments
16.1.7.4 MnM view
16.1.8 SUMITOMO CHEMICAL CO., LTD.
16.1.8.1 Business overview
16.1.8.2 Products/Solutions/Services offered
16.1.8.3 Recent developments
16.1.8.3.1 Deals
16.1.8.3.2 Expansions
16.1.8.4 MnM view
16.1.9 NUFARM
16.1.9.1 Business overview
16.1.9.2 Products/Solutions/Services offered
16.1.9.3 Recent developments
16.1.9.3.1 Product launches
16.1.9.3.2 Deals
16.1.9.4 MnM view
16.1.10 PRO FARM GROUP
16.1.10.1 Business overview
16.1.10.2 Products/Solutions/Services offered
16.1.10.3 Recent developments
16.1.10.3.1 Product launches
16.1.10.4 MnM view
16.2 ANIMAL BIOTECHNOLOGY COMPANIES
16.2.1 ZOETIS SERVICES LLC
16.2.1.1 Business overview
16.2.1.2 Products/Solutions/Services offered
16.2.1.3 Recent developments
16.2.1.3.1 Other developments
16.2.1.3.2 Expansions
16.2.1.4 MnM view
16.2.1.4.1 Key strengths
16.2.1.4.2 Strategic choices
16.2.1.4.3 Weaknesses and competitive threats
16.2.2 ELANCO OR ITS AFFILIATES
16.2.2.1 Business overview
16.2.2.2 Products/Solutions/Services offered
16.2.2.3 Recent developments
16.2.2.3.1 Product launches
16.2.2.4 MnM view
16.2.2.4.1 Key strengths
16.2.2.4.2 Strategic choices
16.2.2.4.3 Weaknesses and competitive threats
16.2.3 MERCK & CO., INC.
16.2.3.1 Business overview
16.2.3.2 Products/Solutions/Services offered
16.2.3.3 Recent developments
16.2.3.3.1 Expansions
16.2.3.4 MnM view
16.2.3.4.1 Key strengths
16.2.3.4.2 Strategic choices
16.2.3.4.3 Weaknesses and competitive threats
16.2.4 CEVA
16.2.4.1 Business overview
16.2.4.2 Products/Solutions/Services offered
16.2.4.3 Recent developments
16.2.4.3.1 Expansions
16.2.4.4 MnM view
16.2.5 VIRBAC
16.2.5.1 Business overview
16.2.5.2 Products/Solutions/Services offered
16.2.5.3 Recent developments
16.2.5.3.1 Product launches
16.2.5.4 MnM view
16.2.5.4.1 Key strengths
16.2.5.4.2 Strategic choices
16.2.5.4.3 Weaknesses and competitive threats
16.2.6 HESTER BIOSCIENCES LIMITED
16.2.6.1 Business overview
16.2.6.2 Products/Solutions/Services offered
16.2.6.3 MnM view
16.2.7 GENUS PLC
16.2.7.1 Business overview
16.2.7.2 Products/Solutions/Services offered
16.2.7.3 MnM view
16.2.8 VAXXINOVA
16.2.8.1 Business overview
16.2.8.2 Products/Solutions/Services offered
16.2.8.3 MnM view
16.2.9 AB VISTA
16.2.9.1 Business overview
16.2.9.2 Products/Solutions/Services offered
16.2.9.3 MnM view
16.2.10 BOEHRINGER INGELHEIM INTERNATIONAL GMBH
16.2.10.1 Business overview
16.2.10.2 Products/Solutions/Services offered
16.2.10.3 Recent developments
16.2.10.3.1 Product launches
16.2.10.4 MnM view
16.2.10.4.1 Key strengths
16.2.10.4.2 Strategic choices
16.2.10.4.3 Weaknesses and competitive threats
16.3 MICROBE BIOTECHNOLOGY COMPANIES
16.3.1 VALENT U.S.A. LLC
16.3.2 NOVONESIS GROUP
16.3.3 INDIGO AG, INC.
16.3.4 PIVOT BIO
16.3.5 BIOATLANTIS LTD.
16.3.6 CERTIS USA L.L.C.
16.3.7 ZYMOLENT BIOSCIENCES PVT. LTD.
16.3.8 AGRICEN
16.3.9 VARSHA BIOSCIENCE AND TECHNOLOGY INDIA PVT LTD.
16.3.10 GROUNDWORK BIOAG
17 ADJACENT AND RELATED MARKETS
17.1 INTRODUCTION
17.2 LIMITATIONS
17.3 PLANT BIOTECHNOLOGY MARKET
17.3.1 MARKET DEFINITION
17.3.2 MARKET OVERVIEW
17.4 AGRICULTURAL MICROBIALS MARKET
17.4.1 MARKET DEFINITION
17.4.2 AGRICULTURAL MICROBIALS MARKET, BY APPLICATION
18 APPENDIX
18.1 DISCUSSION GUIDE
18.2 KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL
18.3 CUSTOMIZATION OPTIONS
18.4 RELATED REPORTS
18.5 AUTHOR DETAILS
1.1 STUDY OBJECTIVES
1.2 MARKET DEFINITION
1.3 STUDY SCOPE
1.3.1 MARKET SEGMENTATION AND REGIONS COVERED
1.3.2 INCLUSIONS AND EXCLUSIONS
1.3.3 YEARS CONSIDERED
1.4 UNITS CONSIDERED
1.4.1 CURRENCY CONSIDERED
1.5 STAKEHOLDERS
2 RESEARCH METHODOLOGY
2.1 RESEARCH DATA
2.1.1 SECONDARY DATA
2.1.1.1 Key data from secondary sources
2.1.2 PRIMARY DATA
2.1.2.1 Key data from primary sources
2.1.2.2 Key primary participants
2.1.2.2.1 AGRICULTURE BIOTECHNOLOGY COMPANIES
2.1.2.3 Breakdown of primary interviews
2.1.2.4 Key industry insights
2.2 MARKET SIZE ESTIMATION
2.2.1 BOTTOM-UP APPROACH
2.2.2 TOP-DOWN APPROACH
2.3 DATA TRIANGULATION
2.4 FACTOR ANALYSIS
2.5 RESEARCH ASSUMPTIONS
2.6 RESEARCH LIMITATIONS
3 EXECUTIVE SUMMARY
4 PREMIUM INSIGHTS
4.1 AGRICULTURE BIOTECHNOLOGY MARKET OVERVIEW
4.2 AGRICULTURE BIOTECHNOLOGY MARKET: GROWTH RATES OF MAJOR REGIONAL SUBMARKETS
4.3 EUROPE: AGRICULTURE BIOTECHNOLOGY MARKET FOR PLANT BIOTECHNOLOGY, BY TYPE AND COUNTRY
4.4 AGRICULTURE BIOTECHNOLOGY MARKET, BY ORGANISM TYPE AND REGION
4.5 MICROBIAL BIOTECHNOLOGY MARKET, BY TECHNOLOGY
4.6 ANIMAL BIOTECHNOLOGY MARKET, BY APPLICATION
4.7 PLANT BIOTECHNOLOGY MARKET, BY APPLICATION
5 MARKET OVERVIEW
5.1 INTRODUCTION
5.2 MARKET DYNAMICS
5.2.1 DRIVERS
5.2.1.1 Growing Need for Sustainable Food Production
5.2.1.2 Government Support and Regulatory Approvals
5.2.1.3 Rising Focus on Reducing Chemical Inputs
5.2.2 RESTRAINTS
5.2.2.1 Public Perception and Ethical Concerns
5.2.2.2 Infrastructure and Cold Chain Limitations
5.2.3 OPPORTUNITIES
5.2.3.1 Expansion in Emerging Economies
5.2.3.2 Focus on Carbon-negative and Regenerative Agriculture
5.2.3.3 Growth in Microbial and Bio-based Inputs
5.2.4 CHALLENGES
5.2.4.1 Regulatory Uncertainty and Trade Barriers
5.2.4.2 Dominance of Few Multinational Players
5.2.4.3 Climate and Disease Variability
5.3 IMPACT OF GEN AI ON AGRICULTURE BIOTECHNOLOGY
5.3.1 INTRODUCTION
5.3.2 USE OF GEN AI IN AGRICULTURE BIOTECHNOLOGY
5.3.3 CASE STUDY ANALYSIS
5.3.3.1 Using Gen AI to Enhance Crop Disease Diagnostics via Synthetic Imagery
5.3.3.2 PhytoSynth: Generative AI for Crop Disease Data Generation
5.3.4 IMPACT ON AGRICULTURE BIOTECHNOLOGY MARKET
5.3.5 ADJACENT ECOSYSTEM WORKING ON GEN AI
6 INDUSTRY TRENDS
6.1 INTRODUCTION
6.2 PORTER’S FIVE FORCES ANALYSIS
6.2.1 INTENSITY OF COMPETITIVE RIVALRY
6.2.2 BARGAINING POWER OF SUPPLIERS
6.2.3 BARGAINING POWER OF BUYERS
6.2.4 THREAT OF SUBSTITUTES
6.2.5 THREAT OF NEW ENTRANTS
6.3 MACROECONOMIC INDICATORS
6.3.1 GLOBAL POPULATION GROWTH & FOOD DEMAND
6.3.2 STABLE GLOBAL GDP GROWTH AND MACRO PROJECTIONS
6.4 SUPPLY CHAIN ANALYSIS
6.5 VALUE CHAIN ANALYSIS
6.6 ECOSYSTEM ANALYSIS
6.6.1 DEMAND SIDE
6.6.2 SUPPLY SIDE
6.7 INDICATIVE PRICING ANALYSIS
6.7.1 INDICATIVE PRICING ANALYSIS, BY KEY COMPANY AND ORGANISM
6.7.2 INDICATIVE PRICING BY REGION
6.8 TRADE ANALYSIS
6.8.1 TRADE ANALYSIS OF HS CODE 843280: PREPARED CULTURE MEDIA FOR DEVELOPMENT OR MAINTENANCE OF MICROORGANISMS, INCLUDING VIRUSES AND THE LIKE, OR OF PLANT, HUMAN, OR ANIMAL CELLS
6.8.1.1 Export Trends of Agriculture Biotechnology under HS Code 382100 (2020–2024)
6.8.1.2 Import Trends of Agriculture Biotechnology under HS Code 382100 (2020–2024)
6.9 KEY CONFERENCES & EVENTS
6.10 TRENDS IMPACTING CUSTOMERS’ BUSINESSES
6.11 INVESTMENT AND FUNDING SCENARIO
6.12 CASE STUDY ANALYSIS
6.12.1 PIVOT BIO’S GENE-EDITED NITROGEN-FIXING MICROBES (2025)
6.12.2 NOVONESIS MICROBIAL SEED INOCULANT (JUMPSTART®) (2024)
6.12.3 RECOMBINETICS — GENE-EDITED LIVESTOCK FOR DISEASE RESISTANCE AND WELFARE ENHANCEMENT (2024)
6.13 IMPACT OF 2025 US TARIFF - AGRICULTURE BIOTECHNOLOGY MARKET
6.13.1 INTRODUCTION
6.13.2 KEY TARIFF RATES
6.13.3 PRICE IMPACT ANALYSIS
6.13.4 IMPACT ON COUNTRY/REGION
6.13.4.1 United States
6.13.4.2 European Union
6.13.4.3 China
6.13.5 IMPACT ON END-USE INDUSTRIES
7 CUSTOMER LANDSCAPE & BUYER BEHAVIOR
7.1 INTRODUCTION
7.2 DECISION-MAKING PROCESS
7.3 BUYER STAKEHOLDERS AND BUYING EVALUATION CRITERIA
7.3.1 KEY STAKEHOLDERS IN BUYING PROCESS
7.3.2 BUYING CRITERIA
7.4 ADOPTION BARRIERS & INTERNAL CHALLENGES
7.5 UNMET NEEDS FROM VARIOUS END-USE INDUSTRIES
7.6 MARKET PROFITABILITY
8 STRATEGIC DISRUPTION THROUGH TECHNOLOGY, PATENTS, DIGITAL, AND AI ADOPTION
8.1 INTRODUCTION
8.2 KEY EMERGING TECHNOLOGIES
8.3 COMPLEMENTARY TECHNOLOGIES
8.4 TECHNOLOGY/PRODUCT ROADMAP
8.5 PATENT ANALYSIS
8.5.1 LIST OF MAJOR PATENTS
8.6 FUTURE APPLICATIONS
8.7 IMPACT OF AI/GEN AI ON AGRICULTURE BIOTECHNOLOGY MARKET
8.7.1 TOP USE CASES AND MARKET POTENTIAL
8.7.1.1 AI Use Cases in Agriculture Biotechnology Market
8.7.1.1.1 AI-driven Genomic Selection and Trait Discovery
8.7.1.1.2 Precision Bio-input Design and Microbial Optimization
8.7.1.1.3 Market Potential Impact of AI in Agricultural Biotechnology
8.7.1.1.4 Acceleration of R&D and Commercialization Pipelines
8.7.1.1.5 Enabling Data-driven Sustainable Agriculture and Global Scalability
8.7.2 BEST PRACTICES IN AGRICULTURE BIOTECHNOLOGY PROCESSING
8.7.3 CASE STUDIES OF AI IMPLEMENTATION IN AGRICULTURE BIOTECHNOLOGY MARKET
8.7.3.1 Using Gen AI to Enhance Crop Disease Diagnostics via Synthetic Imagery
8.7.3.2 PhytoSynth: Generative AI for Crop Disease Data Generation
8.7.4 INTERCONNECTED & ADJACENT ECOSYSTEMS AND IMPACT ON MARKET PLAYERS
8.7.5 CLIENTS’ READINESS TO ADOPT GENERATIVE AI IN AGRICULTURE BIOTECHNOLOGY MARKET
8.8 SUCCESS STORIES AND REAL-WORLD APPLICATIONS
9 SUSTAINABILITY AND REGULATORY LANDSCAPE
9.1 INTRODUCTION
9.2 REGIONAL REGULATIONS AND COMPLIANCE
9.2.1 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
9.2.2 INDUSTRY STANDARDS
9.3 SUSTAINABILITY INITIATIVES
9.3.1 CARBON IMPACT AND ECO-APPLICATIONS OF AGRICULTURE BIOTECHNOLOGY
9.4 SUSTAINABILITY IMPACT AND REGULATORY POLICY INITIATIVES
9.5 CERTIFICATIONS, LABELING, ECO-STANDARDS
10 AGRICULTURE BIOTECHNOLOGY MARKET, BY TYPE OF ORGANISM
10.1 INTRODUCTION
10.2 PLANTS
10.2.1 GROWING GLOBAL FOOD DEMAND, CLIMATE CHANGE RESILIENCE, AND SUSTAINABILITY GOALS ACCELERATING ADOPTION OF PLANT BIOTECHNOLOGY
10.3 ANIMALS
10.3.1 RISING PROTEIN DEMAND, DISEASE PREVENTION NEEDS, AND SUSTAINABLE LIVESTOCK PRODUCTION DRIVING ANIMAL BIOTECHNOLOGY ADVANCEMENTS
10.4 MICROBIALS
10.4.1 RISING DEMAND FOR SUSTAINABLE SOIL HEALTH, BIOFERTILIZERS, AND ECO-FRIENDLY PEST CONTROL DRIVES MICROBIAL BIOTECHNOLOGY GROWTH
11 AGRICULTURE BIOTECHNOLOGY MARKET, BY TYPE
11.1 INTRODUCTION
11.2 PLANT BIOTECHNOLOGY MARKET, BY TYPE
11.2.1 GROWING FOCUS ON ENHANCING CROP YIELD, STRESS RESISTANCE, AND SUSTAINABILITY
11.2.2 GENETIC MODIFICATION
11.2.2.1 Crop protection (Biopesticides, Herbicide-tolerant Traits)
11.2.2.1.1 Rising pest resistance, yield loss, and sustainability goals drive innovation in biotechnology-based crop protection
11.2.2.2 Soil enhancement (Biofertilizers, Microbial Solutions)
11.2.2.2.1 Declining soil fertility and sustainable farming practices are driving demand for biotechnology-based soil enhancement solutions
11.2.2.3 Stress tolerance (Drought/Heat-resistant Crops)
11.2.2.3.1 Climate change, erratic weather, and yield instability are driving demand for stress-tolerant biotechnology crops
11.2.2.4 Animal biotechnology market, by type
11.2.2.4.1 Focus on improving livestock productivity, health, and genetic performance
11.2.3 TRANSGENIC ANIMALS
11.2.3.1 Animal vaccine development
11.2.3.1.1 Increasing livestock diseases and zoonotic threats drive demand for advanced biotechnology-based animal vaccine solutions
11.2.3.2 Feed additives & nutrient optimization
11.2.3.2.1 Rising demand for efficient, sustainable livestock production drives adoption of biotechnology-based feed additives globally
11.2.3.3 Animal health diagnostics
11.2.3.3.1 Growing disease incidence and need for early detection drive innovation in biotechnology-based animal diagnostics
11.2.3.4 Microbial biotechnology market, by type
11.2.3.4.1 Expanding use of microbes in agriculture enhances yield and sustainability
11.2.4 MICROBIAL BIOFERTILIZERS
11.2.4.1 Biocontrol agents (Fungi, Bacteria)
11.2.4.1.1 Stringent pesticide regulations and growing demand for residue-free, sustainable crop protection accelerate biocontrol adoption globally
11.2.4.2 Microbial enzymes & biostimulants
11.2.4.2.1 Rising demand for eco-friendly, stress-resilient crop enhancement solutions drives microbial enzyme and biostimulant adoption globally
11.2.4.3 Microbial genomics & fermentation
11.2.4.3.1 Advancements in microbial genomics and precision fermentation enable high-efficiency, scalable bio-based agricultural innovations globally
12 AGRICULTURE BIOTECHNOLOGY MARKET, BY APPLICATION
12.1 INTRODUCTION
12.2 PLANT BIOTECHNOLOGY MARKET, BY APPLICATION
12.2.1 CROP PROTECTION
12.2.1.1 Increasing pest resistance and need for sustainable pest control drive innovation in biotech crop protection
12.2.2 YIELD ENHANCEMENT
12.2.2.1 Rising food demand and limited arable land accelerate adoption of high-yield biotechnology-based crop systems
12.2.3 NUTRITIONAL QUALITY IMPROVEMENT
12.2.3.1 Rising focus on combating micronutrient deficiency fuels demand for biotechnology-based nutritional crop improvement
12.2.4 CLIMATE-RESILIENT CROPS
12.2.4.1 Intensifying climate variability and food security concerns drive investment in biotechnology-based resilient crop development
12.3 ANIMAL BIOTECHNOLOGY MARKET, BY APPLICATION
12.3.1 DISEASE RESISTANCE
12.3.1.1 Rising livestock disease outbreaks and antibiotic resistance drive adoption of genetic and molecular resistance solutions
12.3.2 GROWTH & PRODUCTIVITY ENHANCEMENT
12.3.2.1 Increasing protein demand and emission-reduction mandates promote biotechnology adoption for livestock growth and productivity enhancement
12.3.3 ANIMAL WELFARE SOLUTIONS
12.3.3.1 Rising ethical concerns and regulatory focus on humane production drive demand for biotechnology-enabled animal welfare systems
12.3.4 VETERINARY THERAPEUTICS
12.3.4.1 Growing prevalence of zoonotic diseases and advancements in biologics fuel growth of veterinary biotechnology therapeutics
12.4 MICROBIAL BIOTECHNOLOGY MARKET, BY APPLICATION
12.4.1 SOIL HEALTH MANAGEMENT
12.4.1.1 Increasing focus on regenerative agriculture and soil restoration drives adoption of microbial soil health management technologies
12.4.2 PEST & DISEASE CONTROL
12.4.2.1 Rising pesticide restrictions and demand for organic produce drive adoption of microbial pest control solutions
12.4.3 SUSTAINABLE NUTRIENT CYCLING
12.4.3.1 Growing nutrient inefficiency and fertilizer price volatility accelerate adoption of microbial nutrient cycling technologies
12.4.4 BIOREMEDIATION & WASTE UTILIZATION
12.4.4.1 Rising agricultural waste generation and environmental pollution drive adoption of microbial bioremediation technologies
13 AGRICULTURE BIOTECHNOLOGY MARKET, BY TECHNOLOGY
13.1 INTRODUCTION
13.2 PLANT BIOTECHNOLOGY MARKET, BY TECHNOLOGY
13.2.1 TISSUE CULTURE
13.2.1.1 Growing need for disease-free, high-quality planting materials and export-grade crops accelerates tissue culture adoption globally
13.2.2 SOMATIC HYBRIDIZATION
13.2.2.1 Advancements in cell fusion and interspecies hybridization foster innovation in developing resilient and high-yield crop hybrids
13.2.3 MOLECULAR DIAGNOSTICS
13.2.3.1 Increasing global biosecurity regulations and focus on disease-free seed trade enhance molecular diagnostic adoption in agriculture
13.2.4 GENETIC ENGINEERING
13.2.4.1 Genetic engineering represents most transformative technology in modern plant biotechnology
13.3 ANIMAL BIOTECHNOLOGY MARKET, BY TECHNOLOGY
13.3.1 EMBRYO RESCUE & TRANSFER
13.3.1.1 Growing demand for genetic improvement, reproductive efficiency, and conservation drives widespread adoption of embryo transfer technologies
13.3.2 GENETIC ENGINEERING & CRISPR
13.3.2.1 Expanding use of CRISPR-Cas9 in livestock breeding drives precision genetic improvement and sustainability in animal farming
13.3.3 MOLECULAR DIAGNOSTICS
13.3.3.1 Rising livestock disease incidence and demand for rapid, accurate pathogen detection bolster molecular diagnostic adoption globally
13.3.4 VACCINE BIOTECHNOLOGIES
13.3.4.1 Rising zoonotic disease threats and focus on antibiotic-free livestock production accelerate biotech vaccine innovations globally
13.4 MICROBIAL BIOTECHNOLOGY MARKET, BY TECHNOLOGY
13.4.1 FERMENTATION TECHNOLOGY
13.4.1.1 Increasing use of sustainable biofertilizers and precision fermentation drives growth in microbial input production technologies
13.4.2 METAGENOMICS & MICROBIAL GENOMICS
13.4.2.1 Expanding soil microbiome research and AI-based genomic analysis accelerate innovation in precision microbial biotechnology
13.4.3 MOLECULAR MARKER-ASSISTED SELECTION
13.4.3.1 Rising need for efficient microbial strain identification promotes adoption of molecular marker-assisted selection technologies
13.4.4 SYNTHETIC BIOLOGY
13.4.4.1 Expanding investments in engineered microbes and metabolic design accelerate adoption of synthetic biology in agriculture and biotechnology
14 AGRICULTURE BIOTECHNOLOGY MARKET, BY REGION
14.1 INTRODUCTION
14.2 NORTH AMERICA
14.2.1 US
14.2.1.1 Expanding bioengineering investments, AI-integrated field trials, and streamlined GMO regulations drive US biotechnology market leadership
14.2.2 CANADA
14.2.2.1 Supportive biosafety regulations and strong genomic research collaborations boost biotechnology advancement and sustainability in Canada
14.2.3 MEXICO
14.2.3.1 Expanding gene-editing research and sustainable agriculture policies accelerate biotechnology adoption and innovation in Mexico
14.3 EUROPE
14.3.1 GERMANY
14.3.1.1 Strong federal R&D support and industrial-scale bio-innovation reinforce Germany’s leadership in sustainable agricultural biotechnology
14.3.2 ITALY
14.3.2.1 Expanding bioinput research programs and regional sustainability initiatives accelerate biotechnology adoption in Italy’s agri-sector
14.3.3 FRANCE
14.3.3.1 Strong government R&D investment and progressive biosafety policies enhance France’s leadership in sustainable agricultural biotechnology
14.3.4 SPAIN
14.3.4.1 Expanding gene-editing research and strong government funding boost Spain’s sustainable agricultural biotechnology development
14.3.5 UK
14.3.5.1 Regulatory reforms and strong R&D investments strengthen UK’s leadership in precision agricultural biotechnology innovation
14.3.6 REST OF EUROPE
14.4 ASIA PACIFIC
14.4.1 CHINA
14.4.1.1 Expanding GMO approvals and strong state-led R&D investments reinforce China’s leadership in agricultural biotechnology innovation
14.4.2 INDIA
14.4.2.1 Government-led biotech missions and microbial innovation drive India’s agricultural transformation toward sustainable productivity growth
14.4.3 JAPAN
14.4.3.1 Strong government funding and innovation-driven industry partnerships accelerate Japan’s agricultural biotechnology advancement
14.4.4 AUSTRALIA & NEW ZEALAND
14.4.4.1 Progressive gene-editing reforms and climate-resilient R&D accelerate biotechnology growth in Australia and New Zealand
14.4.5 REST OF ASIA PACIFIC
14.5 SOUTH AMERICA
14.5.1 BRAZIL
14.5.1.1 Expanding GMO approvals and microbial innovation solidify Brazil’s leadership in agricultural biotechnology development
14.5.2 ARGENTINA
14.5.2.1 Global leadership in GM wheat and microbial bioinputs strengthens Argentina’s agricultural biotechnology innovation capacity
14.5.3 REST OF SOUTH AMERICA
14.6 REST OF THE WORLD
14.6.1 MIDDLE EAST
14.6.1.1 Government-backed innovation and food security strategies drive biotechnology adoption across Middle East’s arid regions
14.6.2 AFRICA
14.6.2.1 Expanding GM approvals and microbial innovation strengthen Africa’s resilience in sustainable agricultural biotechnology adoption
15 COMPETITIVE LANDSCAPE
15.1 OVERVIEW
15.2 KEY PLAYERS’ STRATEGIES, 2022–2024
15.3 REVENUE ANALYSIS, 2022–2024
15.4 MARKET SHARE ANALYSIS, 2024
15.5 BRAND/PRODUCT COMPARISON
15.5.1 BAYER AG (GERMANY)
15.5.2 SYNGENTA AG (SWITZERLAND)
15.5.3 CORTEVA (US)
15.5.4 ZOETIS INC. (US)
15.5.5 NOVONESIS GROUP (DENMARK)
15.6 COMPANY VALUATION AND FINANCIAL METRICS
15.6.1 COMPANY VALUATION
15.6.2 EV/EBITDA
15.7 PLANT BIOTECHNOLOGY COMPANY EVALUATION MATRIX: KEY PLAYERS, 2024
15.7.1 STARS
15.7.2 EMERGING LEADERS
15.7.3 PERVASIVE PLAYERS
15.7.4 PARTICIPANTS
15.7.5 COMPANY FOOTPRINT: KEY PLAYERS, 2024
15.7.5.1 Company footprint
15.7.5.2 Region footprint
15.7.5.3 Type footprint
15.7.5.4 Application footprint
15.8 ANIMAL BIOTECHNOLOGY COMPANY EVALUATION MATRIX: KEY PLAYERS, 2024
15.8.1 STARS
15.8.2 EMERGING LEADERS
15.8.3 PERVASIVE PLAYERS
15.8.4 PARTICIPANTS
15.8.5 COMPANY FOOTPRINT: KEY PLAYERS, 2024
15.8.5.1 Company footprint
15.8.5.2 Region footprint
15.8.5.3 Type footprint
15.8.5.4 Application footprint
15.9 MICROBIAL BIOTECHNOLOGY COMPANY EVALUATION MATRIX: KEY PLAYERS, 2024
15.9.1 STARS
15.9.2 EMERGING LEADERS
15.9.3 PERVASIVE PLAYERS
15.9.4 PARTICIPANTS
15.9.5 COMPANY FOOTPRINT: KEY PLAYERS, 2024
15.9.5.1 Company footprint
15.9.5.2 Region footprint
15.9.5.3 Type footprint
15.9.5.4 Application footprint
15.10 COMPETITIVE SCENARIO
15.10.1 PRODUCT LAUNCHES
15.10.2 DEALS
15.10.3 EXPANSIONS
16 COMPANY PROFILES
16.1 PLANT BIOTECHNOLOGY COMPANIES
16.1.1 BASF SE
16.1.1.1 Business overview
16.1.1.2 Products/Solutions/Services offered
16.1.1.3 Recent developments
16.1.1.3.1 Product launches
16.1.1.3.2 Deals
16.1.1.3.3 Expansions
16.1.1.4 MnM view
16.1.1.4.1 Key strengths
16.1.1.4.2 Strategic choices
16.1.1.4.3 Weaknesses and competitive threats
16.1.2 BAYER AG
16.1.2.1 Business overview
16.1.2.2 Products/Solutions/Services offered
16.1.2.3 Recent developments
16.1.2.3.1 Product launches
16.1.2.3.2 Deals
16.1.2.3.3 Expansions
16.1.2.4 MnM view
16.1.2.4.1 Key strengths
16.1.2.4.2 Strategic choices
16.1.2.4.3 Weaknesses and competitive threats
16.1.3 CORTEVA AGRISCIENCE
16.1.3.1 Business overview
16.1.3.2 Products/Solutions/Services offered
16.1.3.3 Recent developments
16.1.3.3.1 Product launches
16.1.3.3.2 Deals
16.1.3.4 MnM view
16.1.3.4.1 Key strengths
16.1.3.4.2 Strategic choices
16.1.3.4.3 Weaknesses and competitive threats
16.1.4 SYNGENTA
16.1.4.1 Business overview
16.1.4.2 Products/Solutions/Services offered
16.1.4.3 Recent developments
16.1.4.3.1 Product launches
16.1.4.3.2 Deals
16.1.4.3.3 Expansions
16.1.4.4 MnM view
16.1.4.4.1 Key strengths
16.1.4.4.2 Strategic choices
16.1.4.4.3 Weaknesses and competitive threats
16.1.5 KWS SAAT SE & CO. KGAA
16.1.5.1 Business overview
16.1.5.2 Products/Solutions/Services offered
16.1.5.3 Recent developments
16.1.5.3.1 Product launches
16.1.5.3.2 Deals
16.1.5.3.3 Other developments
16.1.5.4 MnM view
16.1.5.4.1 Key strengths
16.1.5.4.2 Strategic choices
16.1.5.4.3 Weaknesses and competitive threats
16.1.6 UPL
16.1.6.1 Business overview
16.1.6.2 Products/Solutions/Services offered
16.1.6.3 Recent developments
16.1.6.3.1 Product launches
16.1.6.3.2 Deals
16.1.6.4 MnM view
16.1.6.4.1 Key strengths
16.1.6.4.2 Strategic choices
16.1.6.4.3 Weaknesses and competitive threats
16.1.7 FMC CORPORATION
16.1.7.1 Business overview
16.1.7.2 Products/Solutions/Services offered
16.1.7.3 Recent developments
16.1.7.3.1 Product launches
16.1.7.3.2 Deals
16.1.7.3.3 Expansions
16.1.7.3.4 Other developments
16.1.7.4 MnM view
16.1.8 SUMITOMO CHEMICAL CO., LTD.
16.1.8.1 Business overview
16.1.8.2 Products/Solutions/Services offered
16.1.8.3 Recent developments
16.1.8.3.1 Deals
16.1.8.3.2 Expansions
16.1.8.4 MnM view
16.1.9 NUFARM
16.1.9.1 Business overview
16.1.9.2 Products/Solutions/Services offered
16.1.9.3 Recent developments
16.1.9.3.1 Product launches
16.1.9.3.2 Deals
16.1.9.4 MnM view
16.1.10 PRO FARM GROUP
16.1.10.1 Business overview
16.1.10.2 Products/Solutions/Services offered
16.1.10.3 Recent developments
16.1.10.3.1 Product launches
16.1.10.4 MnM view
16.2 ANIMAL BIOTECHNOLOGY COMPANIES
16.2.1 ZOETIS SERVICES LLC
16.2.1.1 Business overview
16.2.1.2 Products/Solutions/Services offered
16.2.1.3 Recent developments
16.2.1.3.1 Other developments
16.2.1.3.2 Expansions
16.2.1.4 MnM view
16.2.1.4.1 Key strengths
16.2.1.4.2 Strategic choices
16.2.1.4.3 Weaknesses and competitive threats
16.2.2 ELANCO OR ITS AFFILIATES
16.2.2.1 Business overview
16.2.2.2 Products/Solutions/Services offered
16.2.2.3 Recent developments
16.2.2.3.1 Product launches
16.2.2.4 MnM view
16.2.2.4.1 Key strengths
16.2.2.4.2 Strategic choices
16.2.2.4.3 Weaknesses and competitive threats
16.2.3 MERCK & CO., INC.
16.2.3.1 Business overview
16.2.3.2 Products/Solutions/Services offered
16.2.3.3 Recent developments
16.2.3.3.1 Expansions
16.2.3.4 MnM view
16.2.3.4.1 Key strengths
16.2.3.4.2 Strategic choices
16.2.3.4.3 Weaknesses and competitive threats
16.2.4 CEVA
16.2.4.1 Business overview
16.2.4.2 Products/Solutions/Services offered
16.2.4.3 Recent developments
16.2.4.3.1 Expansions
16.2.4.4 MnM view
16.2.5 VIRBAC
16.2.5.1 Business overview
16.2.5.2 Products/Solutions/Services offered
16.2.5.3 Recent developments
16.2.5.3.1 Product launches
16.2.5.4 MnM view
16.2.5.4.1 Key strengths
16.2.5.4.2 Strategic choices
16.2.5.4.3 Weaknesses and competitive threats
16.2.6 HESTER BIOSCIENCES LIMITED
16.2.6.1 Business overview
16.2.6.2 Products/Solutions/Services offered
16.2.6.3 MnM view
16.2.7 GENUS PLC
16.2.7.1 Business overview
16.2.7.2 Products/Solutions/Services offered
16.2.7.3 MnM view
16.2.8 VAXXINOVA
16.2.8.1 Business overview
16.2.8.2 Products/Solutions/Services offered
16.2.8.3 MnM view
16.2.9 AB VISTA
16.2.9.1 Business overview
16.2.9.2 Products/Solutions/Services offered
16.2.9.3 MnM view
16.2.10 BOEHRINGER INGELHEIM INTERNATIONAL GMBH
16.2.10.1 Business overview
16.2.10.2 Products/Solutions/Services offered
16.2.10.3 Recent developments
16.2.10.3.1 Product launches
16.2.10.4 MnM view
16.2.10.4.1 Key strengths
16.2.10.4.2 Strategic choices
16.2.10.4.3 Weaknesses and competitive threats
16.3 MICROBE BIOTECHNOLOGY COMPANIES
16.3.1 VALENT U.S.A. LLC
16.3.2 NOVONESIS GROUP
16.3.3 INDIGO AG, INC.
16.3.4 PIVOT BIO
16.3.5 BIOATLANTIS LTD.
16.3.6 CERTIS USA L.L.C.
16.3.7 ZYMOLENT BIOSCIENCES PVT. LTD.
16.3.8 AGRICEN
16.3.9 VARSHA BIOSCIENCE AND TECHNOLOGY INDIA PVT LTD.
16.3.10 GROUNDWORK BIOAG
17 ADJACENT AND RELATED MARKETS
17.1 INTRODUCTION
17.2 LIMITATIONS
17.3 PLANT BIOTECHNOLOGY MARKET
17.3.1 MARKET DEFINITION
17.3.2 MARKET OVERVIEW
17.4 AGRICULTURAL MICROBIALS MARKET
17.4.1 MARKET DEFINITION
17.4.2 AGRICULTURAL MICROBIALS MARKET, BY APPLICATION
18 APPENDIX
18.1 DISCUSSION GUIDE
18.2 KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL
18.3 CUSTOMIZATION OPTIONS
18.4 RELATED REPORTS
18.5 AUTHOR DETAILS
LIST OF TABLES
TABLE 1 USD EXCHANGE RATES, 2020–2024
TABLE 2 AGRICULTURE BIOTECHNOLOGY MARKET SNAPSHOT, 2025 VS. 2030
TABLE 3 AGRICULTURE BIOTECHNOLOGY MARKET: PORTER’S FIVE FORCES ANALYSIS
TABLE 4 INDICATIVE PRICING ANALYSIS BY KEY COMPANIES FOR PLANT BIOTECHNOLOGY
TABLE 5 INDICATIVE PRICING ANALYSIS BY KEY COMPANIES FOR MICROBIAL BIOTECHNOLOGY
TABLE 6 INDICATIVE PRICING ANALYSIS BY KEY COMPANIES FOR ANIMAL BIOTECHNOLOGY
TABLE 7 PLANT BIOTECHNOLOGY – INDICATIVE REGIONAL PRICING, 2024
TABLE 8 MICROBIAL BIOTECHNOLOGY – INDICATIVE REGIONAL PRICING, 2024
TABLE 9 ANIMAL BIOTECHNOLOGY – INDICATIVE REGIONAL PRICING, 2024
TABLE 10 TOP 10 EXPORTERS OF HS CODE 382100, 2020–2024 (USD THOUSAND)
TABLE 11 TOP 10 IMPORTERS OF HS CODE 382100, 2020–2024 (USD THOUSAND)
TABLE 12 TOP 10 EXPORTERS OF HS CODE 382100, 2020–2024 (TONS)
TABLE 13 TOP 10 IMPORTERS OF HS CODE 382100, 2020–2024 (TONS)
TABLE 14 AGRICULTURE BIOTECHNOLOGY MARKET: DETAILED LIST OF CONFERENCES & EVENTS, 2025–2026
TABLE 15 US-ADJUSTED RECIPROCAL TARIFF RATES
TABLE 16 EXPECTED IMPACT LEVEL ON TARGET PRODUCTS WITH RELEVANT HS CODES DUE TO TRUMP TARIFF IMPACT
TABLE 17 EXPECTED TARIFF IMPACT ON END-USE INDUSTRIES
TABLE 18 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR AGRICULTURE BIOTECHNOLOGY TYPE
TABLE 19 KEY BUYING CRITERIA FOR AGRICULTURE BIOTECHNOLOGY MARKET, BY TYPE
TABLE 20 LIST OF MAJOR PATENTS FOR AGRICULTURE BIOTECHNOLOGY MARKET, 2021–2024
TABLE 21 NORTH AMERICA: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
TABLE 22 EUROPE: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
TABLE 23 ASIA PACIFIC: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
TABLE 24 SOUTH AMERICA: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
TABLE 25 MIDDLE EAST & AFRICA: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
TABLE 26 AGRICULTURE BIOTECHNOLOGY MARKET, BY TYPE OF ORGANISM, 2020–2024 (USD MILLION)
TABLE 27 AGRICULTURE BIOTECHNOLOGY MARKET, BY TYPE OF ORGANISM, 2025–2030 (USD MILLION)
TABLE 28 PLANTS: AGRICULTURE BIOTECHNOLOGY MARKET, BY REGION, 2020–2024 (USD MILLION)
TABLE 29 PLANTS: AGRICULTURE BIOTECHNOLOGY MARKET, BY REGION, 2025–2030 (USD MILLION)
TABLE 30 ANIMALS: AGRICULTURE BIOTECHNOLOGY MARKET, BY REGION, 2020–2024 (USD MILLION)
TABLE 31 ANIMALS: AGRICULTURE BIOTECHNOLOGY MARKET, BY REGION, 2025–2030 (USD MILLION)
TABLE 32 MICROBIAL: AGRICULTURE BIOTECHNOLOGY MARKET, BY REGION, 2020–2024 (USD MILLION)
TABLE 33 MICROBIAL: AGRICULTURE BIOTECHNOLOGY MARKET, BY REGION, 2025–2030 (USD MILLION)
TABLE 34 PLANT BIOTECHNOLOGY MARKET, BY TYPE, 2020–2024 (USD MILLION)
TABLE 35 PLANT BIOTECHNOLOGY MARKET, BY TYPE, 2025–2030 (USD MILLION)
TABLE 36 CROP PROTECTION & SOIL ENHANCEMENT: PLANT BIOTECHNOLOGY MARKET, BY PRODUCT, 2020-2024 (THOUSAND METRIC TONS)
TABLE 37 CROP PROTECTION & SOIL ENHANCEMENT: PLANT BIOTECHNOLOGY MARKET, BY PRODUCT, 2025-2030 (THOUSAND METRIC TONS)
TABLE 38 CROP PROTECTION & SOIL ENHANCEMENT: PLANT BIOTECHNOLOGY MARKET, BY REGION, 2020-2024 (THOUSAND METRIC TONS)
TABLE 39 CROP PROTECTION & SOIL ENHANCEMENT: PLANT BIOTECHNOLOGY MARKET, BY REGION, 2025-2030 (THOUSAND METRIC TONS)
TABLE 40 BIOPESTICIDES: PLANT BIOTECHNOLOGY MARKET, BY REGION, 2020-2024 (THOUSAND METRIC TONS)
TABLE 41 BIOPESTICIDES: PLANT BIOTECHNOLOGY MARKET, BY REGION, 2025-2030 (THOUSAND METRIC TONS)
TABLE 42 BIOFERTILIZERS: PLANT BIOTECHNOLOGY MARKET, BY REGION, 2020-2024 (THOUSAND METRIC TONS)
TABLE 43 BIOFERTILIZERS: PLANT BIOTECHNOLOGY MARKET, BY REGION, 2025-2030 (THOUSAND METRIC TONS)
TABLE 44 PLANT GROWTH REGULATORS: PLANT BIOTECHNOLOGY MARKET, BY REGION, 2020-2024 (THOUSAND METRIC TONS)
TABLE 45 PLANT GROWTH REGULATORS: PLANT BIOTECHNOLOGY MARKET, BY REGION, 2025-2030 (THOUSAND METRIC TONS)
TABLE 46 ANIMAL BIOTECHNOLOGY MARKET, BY TYPE, 2020–2024 (USD MILLION)
TABLE 47 ANIMAL BIOTECHNOLOGY MARKET, BY TYPE, 2025–2030 (USD MILLION)
TABLE 48 MICROBIAL BIOTECHNOLOGY MARKET, BY TYPE, 2020–2024 (USD MILLION)
TABLE 49 MICROBIAL BIOTECHNOLOGY MARKET, BY TYPE, 2025–2030 (USD MILLION)
TABLE 50 MICROBIAL BIOTECHNOLOGY MARKET, BY TYPE, 2020-2024 (THOUSAND METRIC TONS)
TABLE 51 MICROBIAL BIOTECHNOLOGY MARKET, BY TYPE, 2025-2030 (THOUSAND METRIC TONS)
TABLE 52 MICROBIAL BIOFERTILIZERS & MICROBIAL BIOSTIMULANTS: AGRICULTURAL MICROBIALS MARKET, BY REGION, 2020-2024 (THOUSAND METRIC TONS)
TABLE 53 MICROBIAL BIOFERTILIZERS & MICROBIAL BIOSTIMULANTS: AGRICULTURAL MICROBIALS MARKET, BY REGION, 2025-2030 (THOUSAND METRIC TONS)
TABLE 54 MICROBIAL BIOCONTROL AGENTS: AGRICULTURAL MICROBIALS MARKET, BY REGION, 2020-2024 (THOUSAND METRIC TONS)
TABLE 55 MICROBIAL BIOCONTROL AGENTS: AGRICULTURAL MICROBIALS MARKET, BY REGION, 2025-2030 (THOUSAND METRIC TONS)
TABLE 56 PLANT BIOTECHNOLOGY MARKET, BY APPLICATION, 2020–2024 (USD MILLION)
TABLE 57 PLANT BIOTECHNOLOGY MARKET, BY APPLICATION, 2025–2030 (USD MILLION)
TABLE 58 ANIMAL BIOTECHNOLOGY MARKET, BY APPLICATION, 2020–2024 (USD MILLION)
TABLE 59 ANIMAL BIOTECHNOLOGY MARKET, BY APPLICATION, 2025–2030 (USD MILLION)
TABLE 60 MICROBIAL BIOTECHNOLOGY MARKET, BY APPLICATION, 2020–2024 (USD MILLION)
TABLE 61 MICROBIAL BIOTECHNOLOGY MARKET, BY APPLICATION, 2025–2030 (USD MILLION)
TABLE 62 PLANT BIOTECHNOLOGY MARKET, BY TECHNOLOGY, 2020–2024 (USD MILLION)
TABLE 63 PLANT BIOTECHNOLOGY MARKET, BY TECHNOLOGY, 2025–2030 (USD MILLION)
TABLE 64 ANIMAL BIOTECHNOLOGY MARKET, BY TECHNOLOGY, 2020–2024 (USD MILLION)
TABLE 65 ANIMAL BIOTECHNOLOGY MARKET, BY TECHNOLOGY, 2025–2030 (USD MILLION)
TABLE 66 MICROBIAL BIOTECHNOLOGY MARKET, BY TECHNOLOGY, 2020–2024 (USD MILLION)
TABLE 67 MICROBIAL BIOTECHNOLOGY MARKET, BY TECHNOLOGY, 2025–2030 (USD MILLION)
TABLE 68 AGRICULTURE BIOTECHNOLOGY MARKET, BY REGION, 2020–2024 (USD MILLION)
TABLE 69 AGRICULTURE BIOTECHNOLOGY MARKET, BY REGION, 2025–2030 (USD MILLION)
TABLE 70 PLANT BIOTECHNOLOGY MARKET, BY REGION, 2020–2024 (USD MILLION)
TABLE 71 PLANT BIOTECHNOLOGY MARKET, BY REGION, 2025–2030 (USD MILLION)
TABLE 72 ANIMAL BIOTECHNOLOGY MARKET, BY REGION, 2020–2024 (USD MILLION)
TABLE 73 ANIMAL BIOTECHNOLOGY MARKET, BY REGION, 2025–2030 (USD MILLION)
TABLE 74 MICROBIAL BIOTECHNOLOGY MARKET, BY REGION, 2020–2024 (USD MILLION)
TABLE 75 MICROBIAL BIOTECHNOLOGY MARKET, BY REGION, 2025–2030 (USD MILLION)
TABLE 76 NORTH AMERICA: AGRICULTURE BIOTECHNOLOGY MARKET, BY COUNTRY, 2020–2024 (USD MILLION)
TABLE 77 NORTH AMERICA: AGRICULTURE BIOTECHNOLOGY MARKET, BY COUNTRY, 2025–2030 (USD MILLION)
TABLE 78 NORTH AMERICA: PLANT BIOTECHNOLOGY MARKET, BY COUNTRY, 2020–2024 (USD MILLION)
TABLE 79 NORTH AMERICA: PLANT BIOTECHNOLOGY MARKET, BY COUNTRY, 2025–2030 (USD MILLION)
TABLE 80 NORTH AMERICA: PLANT BIOTECHNOLOGY MARKET, BY TYPE, 2020–2024 (USD MILLION)
TABLE 81 NORTH AMERICA: PLANT BIOTECHNOLOGY MARKET, BY TYPE, 2025–2030 (USD MILLION)
TABLE 82 NORTH AMERICAN CROP PROTECTION & SOIL ENHANCEMENT PRODUCTS: PLANT BIOTECHNOLOGY MARKET, BY PRODUCT, 2020-2024 (THOUSAND METRIC TONS)
TABLE 83 NORTH AMERICAN CROP PROTECTION & SOIL ENHANCEMENT PRODUCTS: PLANT BIOTECHNOLOGY MARKET, BY PRODUCT, 2025-2030 (THOUSAND METRIC TONS)
TABLE 84 NORTH AMERICA: PLANT BIOTECHNOLOGY MARKET, BY TECHNOLOGY, 2020–2024 (USD MILLION)
TABLE 85 NORTH AMERICA: PLANT BIOTECHNOLOGY MARKET, BY TECHNOLOGY, 2025–2030 (USD MILLION)
TABLE 86 NORTH AMERICA: PLANT BIOTECHNOLOGY MARKET, BY APPLICATION, 2020–2024 (USD MILLION)
TABLE 87 NORTH AMERICA: PLANT BIOTECHNOLOGY MARKET, BY APPLICATION, 2025–2030 (USD MILLION)
TABLE 88 NORTH AMERICA: ANIMAL BIOTECHNOLOGY MARKET, BY COUNTRY, 2020–2024 (USD MILLION)
TABLE 89 NORTH AMERICA: ANIMAL BIOTECHNOLOGY MARKET, BY COUNTRY, 2025–2030 (USD MILLION)
TABLE 90 NORTH AMERICA: ANIMAL BIOTECHNOLOGY MARKET, BY TYPE, 2020–2024 (USD MILLION)
TABLE 91 NORTH AMERICA: ANIMAL BIOTECHNOLOGY MARKET, BY TYPE, 2025–2030 (USD MILLION)
TABLE 92 NORTH AMERICA: ANIMAL BIOTECHNOLOGY MARKET, BY TECHNOLOGY, 2020–2024 (USD MILLION)
TABLE 93 NORTH AMERICA: ANIMAL BIOTECHNOLOGY MARKET, BY TECHNOLOGY, 2025–2030 (USD MILLION)
TABLE 94 NORTH AMERICA: ANIMAL BIOTECHNOLOGY MARKET, BY APPLICATION, 2020–2024 (USD MILLION)
TABLE 95 NORTH AMERICA: ANIMAL BIOTECHNOLOGY MARKET, BY APPLICATION, 2025–2030 (USD MILLION)
TABLE 96 NORTH AMERICA: MICROBIAL BIOTECHNOLOGY MARKET, BY COUNTRY, 2020–2024 (USD MILLION)
TABLE 97 NORTH AMERICA: MICROBIAL BIOTECHNOLOGY MARKET, BY COUNTRY, 2025–2030 (USD MILLION)
TABLE 98 NORTH AMERICA: MICROBIAL BIOTECHNOLOGY MARKET, BY TYPE, 2020–2024 (USD MILLION)
TABLE 99 NORTH AMERICA: MICROBIAL BIOTECHNOLOGY MARKET, BY TYPE, 2025–2030 (USD MILLION)
TABLE 100 NORTH AMERICA: MICROBIAL BIOTECHNOLOGY MARKET, BY TYPE, 2020-2024 (THOUSAND METRIC TONS)
TABLE 101 NORTH AMERICA: MICROBIAL BIOTECHNOLOGY MARKET, BY TYPE, 2025-2030 (THOUSAND METRIC TONS)
TABLE 102 NORTH AMERICA: MICROBIAL BIOTECHNOLOGY MARKET, BY TECHNOLOGY, 2020–2024 (USD MILLION)
TABLE 103 NORTH AMERICA: MICROBIAL BIOTECHNOLOGY MARKET, BY TECHNOLOGY, 2025–2030 (USD MILLION)
TABLE 104 NORTH AMERICA: MICROBIAL BIOTECHNOLOGY MARKET, BY APPLICATION, 2020–2024 (USD MILLION)
TABLE 105 NORTH AMERICA: MICROBIAL BIOTECHNOLOGY MARKET, BY APPLICATION, 2025–2030 (USD MILLION)
TABLE 106 US: PLANT BIOTECHNOLOGY MARKET, BY TYPE, 2020–2024 (USD MILLION)
TABLE 107 US: PLANT BIOTECHNOLOGY MARKET, BY TYPE, 2025–2030 (USD MILLION)
TABLE 108 US: PLANT BIOTECHNOLOGY MARKET, BY APPLICATION, 2020–2024 (USD MILLION)
TABLE 109 US: PLANT BIOTECHNOLOGY MARKET, BY APPLICATION, 2025–2030 (USD MILLION)
TABLE 110 US: ANIMAL BIOTECHNOLOGY MARKET, BY TYPE, 2020–2024 (USD MILLION)
TABLE 111 US: ANIMAL BIOTECHNOLOGY MARKET, BY TYPE, 2025–2030 (USD MILLION)
TABLE 112 US: ANIMAL BIOTECHNOLOGY MARKET, BY APPLICATION, 2020–2024 (USD MILLION)
TABLE 113 US: ANIMAL BIOTECHNOLOGY MARKET, BY APPLICATION, 2025–2030 (USD MILLION)
TABLE 114 US: MICROBIAL BIOTECHNOLOGY MARKET, BY TYPE, 2020–2024 (USD MILLION)
TABLE 115 US: MICROBIAL BIOTECHNOLOGY MARKET, BY TYPE, 2025–2030 (USD MILLION)
TABLE 116 US: MICROBIAL BIOTECHNOLOGY MARKET, BY APPLICATION, 2020–2024 (USD MILLION)
TABLE 117 US: MICROBIAL BIOTECHNOLOGY MARKET, BY APPLICATION, 2025–2030 (USD MILLION)
TABLE 118 CANADA: PLANT BIOTECHNOLOGY MARKET, BY TYPE, 2020–2024 (USD MILLION)
TABLE 119 CANADA: PLANT BIOTECHNOLOGY MARKET, BY TYPE, 2025–2030 (USD MILLION)
TABLE 120 CANADA: PLANT BIOTECHNOLOGY MARKET, BY APPLICATION, 2020–2024 (USD MILLION)
TABLE 121 CANADA: PLANT BIOTECHNOLOGY MARKET, BY APPLICATION, 2025–2030 (USD MILLION)
TABLE 122 CANADA: ANIMAL BIOTECHNOLOGY MARKET, BY TYPE, 2020–2024 (USD MILLION)
TABLE 123 CANADA: ANIMAL BIOTECHNOLOGY MARKET, BY TYPE, 2025–2030 (USD MILLION)
TABLE 124 CANADA: ANIMAL BIOTECHNOLOGY MARKET, BY APPLICATION, 2020–2024 (USD MILLION)
TABLE 125 CANADA: ANIMAL BIOTECHNOLOGY MARKET, BY APPLICATION, 2025–2030 (USD MILLION)
TABLE 126 CANADA: MICROBIAL BIOTECHNOLOGY MARKET, BY TYPE, 2020–2024 (USD MILLION)
TABLE 127 CANADA: MICROBIAL BIOTECHNOLOGY MARKET, BY TYPE, 2025–2030 (USD MILLION)
TABLE 128 CANADA: MICROBIAL BIOTECHNOLOGY MARKET, BY APPLICATION, 2020–2024 (USD MILLION)
TABLE 129 CANADA: MICROBIAL BIOTECHNOLOGY MARKET, BY APPLICATION, 2025–2030 (USD MILLION)
TABLE 130 MEXICO: PLANT BIOTECHNOLOGY MARKET, BY TYPE, 2020–2024 (USD MILLION)
TABLE 131 MEXICO: PLANT BIOTECHNOLOGY MARKET, BY TYPE, 2025–2030 (USD MILLION)
TABLE 132 MEXICO: PLANT BIOTECHNOLOGY MARKET, BY APPLICATION, 2020–2024 (USD MILLION)
TABLE 133 MEXICO: PLANT BIOTECHNOLOGY MARKET, BY APPLICATION, 2025–2030 (USD MILLION)
TABLE 134 MEXICO: ANIMAL BIOTECHNOLOGY MARKET, BY TYPE, 2020–2024 (USD MILLION)
TABLE 135 MEXICO: ANIMAL BIOTECHNOLOGY MARKET, BY TYPE, 2025–2030 (USD MILLION)
TABLE 136 MEXICO: ANIMAL BIOTECHNOLOGY MARKET, BY APPLICATION, 2020–2024 (USD MILLION)
TABLE 137 MEXICO: ANIMAL BIOTECHNOLOGY MARKET, BY APPLICATION, 2025–2030 (USD MILLION)
TABLE 138 MEXICO: MICROBIAL BIOTECHNOLOGY MARKET, BY TYPE, 2020–2024 (USD MILLION)
TABLE 139 MEXICO: MICROBIAL BIOTECHNOLOGY MARKET, BY TYPE, 2025–2030 (USD MILLION)
TABLE 140 MEXICO: MICROBIAL BIOTECHNOLOGY MARKET, BY APPLICATION, 2020–2024 (USD MILLION)
TABLE 141 MEXICO: MICROBIAL BIOTECHNOLOGY MARKET, BY APPLICATION, 2025–2030 (USD MILLION)
TABLE 142 EUROPE: AGRICULTURE BIOTECHNOLOGY MARKET, BY COUNTRY, 2020–2024 (USD MILLION)
TABLE 143 EUROPE: AGRICULTURE BIOTECHNOLOGY MARKET, BY COUNTRY, 2025–2030 (USD MILLION)
TABLE 144 EUROPE: PLANT BIOTECHNOLOGY MARKET, BY COUNTRY, 2020–2024 (USD MILLION)
TABLE 145 EUROPE: PLANT BIOTECHNOLOGY MARKET, BY COUNTRY, 2025–2030 (USD MILLION)
TABLE 146 EUROPE: PLANT BIOTECHNOLOGY MARKET, BY TYPE, 2020–2024 (USD MILLION)
TABLE 147 EUROPE: PLANT BIOTECHNOLOGY MARKET, BY TYPE, 2025–2030 (USD MILLION)
TABLE 148 EUROPEAN CROP PROTECTION & SOIL ENHANCEMENT PRODUCTS: PLANT BIOTECHNOLOGY MARKET, BY PRODUCT, 2020-2024 (THOUSAND METRIC TONS)
TABLE 149 EUROPEAN CROP PROTECTION & SOIL ENHANCEMENT PRODUCTS: PLANT BIOTECHNOLOGY MARKET, BY PRODUCT, 2025-2030 (THOUSAND METRIC TONS)
TABLE 150 EUROPE: PLANT BIOTECHNOLOGY MARKET, BY TECHNOLOGY, 2020–2024 (USD MILLION)
TABLE 151 EUROPE: PLANT BIOTECHNOLOGY MARKET, BY TECHNOLOGY, 2025–2030 (USD MILLION)
TABLE 152 EUROPE: PLANT BIOTECHNOLOGY MARKET, BY APPLICATION, 2020–2024 (USD MILLION)
TABLE 153 EUROPE: PLANT BIOTECHNOLOGY MARKET, BY APPLICATION, 2025–2030 (USD MILLION)
TABLE 154 EUROPE: ANIMAL BIOTECHNOLOGY MARKET, BY COUNTRY, 2020–2024 (USD MILLION)
TABLE 155 EUROPE: ANIMAL BIOTECHNOLOGY MARKET, BY COUNTRY, 2025–2030 (USD MILLION)
TABLE 156 EUROPE: ANIMAL BIOTECHNOLOGY MARKET, BY TYPE, 2020–2024 (USD MILLION)
TABLE 157 EUROPE: ANIMAL BIOTECHNOLOGY MARKET, BY TYPE, 2025–2030 (USD MILLION)
TABLE 158 EUROPE: ANIMAL BIOTECHNOLOGY MARKET, BY TECHNOLOGY, 2020–2024 (USD MILLION)
TABLE 159 EUROPE: ANIMAL BIOTECHNOLOGY MARKET, BY TECHNOLOGY, 2025–2030 (USD MILLION)
TABLE 160 EUROPE: ANIMAL BIOTECHNOLOGY MARKET, BY APPLICATION, 2020–2024 (USD MILLION)
TABLE 161 EUROPE: ANIMAL BIOTECHNOLOGY MARKET, BY APPLICATION, 2025–2030 (USD MILLION)
TABLE 162 EUROPE: MICROBIAL BIOTECHNOLOGY MARKET, BY COUNTRY, 2020–2024 (USD MILLION)
TABLE 163 EUROPE: MICROBIAL BIOTECHNOLOGY MARKET, BY COUNTRY, 2025–2030 (USD MILLION)
TABLE 164 EUROPE: MICROBIAL BIOTECHNOLOGY MARKET, BY TYPE, 2020–2024 (USD MILLION)
TABLE 165 EUROPE: MICROBIAL BIOTECHNOLOGY MARKET, BY TYPE, 2025–2030 (USD MILLION)
TABLE 166 EUROPE: MICROBIAL BIOTECHNOLOGY MARKET, BY TYPE, 2020-2024 (THOUSAND METRIC TONS)
TABLE 167 EUROPE: MICROBIAL BIOTECHNOLOGY MARKET, BY TYPE, 2025-2030 (THOUSAND METRIC TONS)
TABLE 168 EUROPE: MICROBIAL BIOTECHNOLOGY MARKET, BY TECHNOLOGY, 2020–2024 (USD MILLION)
TABLE 169 EUROPE: MICROBIAL BIOTECHNOLOGY MARKET, BY TECHNOLOGY, 2025–2030 (USD MILLION)
TABLE 170 EUROPE: MICROBIAL BIOTECHNOLOGY MARKET, BY APPLICATION, 2020–2024 (USD MILLION)
TABLE 171 EUROPE: MICROBIAL BIOTECHNOLOGY MARKET, BY APPLICATION, 2025–2030 (USD MILLION)
TABLE 172 GERMANY: PLANT BIOTECHNOLOGY MARKET, BY TYPE, 2020–2024 (USD MILLION)
TABLE 173 GERMANY: PLANT BIOTECHNOLOGY MARKET, BY TYPE, 2025–2030 (USD MILLION)
TABLE 174 GERMANY: PLANT BIOTECHNOLOGY MARKET, BY APPLICATION, 2020–2024 (USD MILLION)
TABLE 175 GERMANY: PLANT BIOTECHNOLOGY MARKET, BY APPLICATION, 2025–2030 (USD MILLION)
TABLE 176 GERMANY: ANIMAL BIOTECHNOLOGY MARKET, BY TYPE, 2020–2024 (USD MILLION)
TABLE 177 GERMANY: ANIMAL BIOTECHNOLOGY MARKET, BY TYPE, 2025–2030 (USD MILLION)
TABLE 178 GERMANY: ANIMAL BIOTECHNOLOGY MARKET, BY APPLICATION, 2020–2024 (USD MILLION)
TABLE 179 GERMANY: ANIMAL BIOTECHNOLOGY MARKET, BY APPLICATION, 2025–2030 (USD MILLION)
TABLE 180 GERMANY: MICROBIAL BIOTECHNOLOGY MARKET, BY TYPE, 2020–2024 (USD MILLION)
TABLE 181 GERMANY: MICROBIAL BIOTECHNOLOGY MARKET, BY TYPE, 2025–2030 (USD MILLION)
TABLE 182 GERMANY: MICROBIAL BIOTECHNOLOGY MARKET, BY APPLICATION, 2020–2024 (USD MILLION)
TABLE 183 GERMANY: MICROBIAL BIOTECHNOLOGY MARKET, BY APPLICATION, 2025–2030 (USD MILLION)
TABLE 184 ITALY: PLANT BIOTECHNOLOGY MARKET, BY TYPE, 2020–2024 (USD MILLION)
TABLE 185 ITALY: PLANT BIOTECHNOLOGY MARKET, BY TYPE, 2025–2030 (USD MILLION)
TABLE 186 ITALY: PLANT BIOTECHNOLOGY MARKET, BY APPLICATION, 2020–2024 (USD MILLION)
TABLE 187 ITALY: PLANT BIOTECHNOLOGY MARKET, BY APPLICATION, 2025–2030 (USD MILLION)
TABLE 188 ITALY: ANIMAL BIOTECHNOLOGY MARKET, BY TYPE, 2020–2024 (USD MILLION)
TABLE 189 ITALY: ANIMAL BIOTECHNOLOGY MARKET, BY TYPE, 2025–2030 (USD MILLION)
TABLE 190 ITALY: ANIMAL BIOTECHNOLOGY MARKET, BY APPLICATION, 2020–2024 (USD MILLION)
TABLE 191 ITALY: ANIMAL BIOTECHNOLOGY MARKET, BY APPLICATION, 2025–2030 (USD MILLION)
TABLE 192 ITALY: MICROBIAL BIOTECHNOLOGY MARKET, BY TYPE, 2020–2024 (USD MILLION)
TABLE 193 ITALY: MICROBIAL BIOTECHNOLOGY MARKET, BY TYPE, 2025–2030 (USD MILLION)
TABLE 194 ITALY: MICROBIAL BIOTECHNOLOGY MARKET, BY APPLICATION, 2020–2024 (USD MILLION)
TABLE 195 ITALY: MICROBIAL BIOTECHNOLOGY MARKET, BY APPLICATION, 2025–2030 (USD MILLION)
TABLE 196 FRANCE: PLANT BIOTECHNOLOGY MARKET, BY TYPE, 2020–2024 (USD MILLION)
TABLE 197 FRANCE: PLANT BIOTECHNOLOGY MARKET, BY TYPE, 2025–2030 (USD MILLION)
TABLE 198 FRANCE: PLANT BIOTECHNOLOGY MARKET, BY APPLICATION, 2020–2024 (USD MILLION)
TABLE 199 FRANCE: PLANT BIOTECHNOLOGY MARKET, BY APPLICATION, 2025–2030 (USD MILLION)
TABLE 200 FRANCE: ANIMAL BIOTECHNOLOGY MARKET, BY TYPE, 2020–2024 (USD MILLION)
TABLE 201 FRANCE: ANIMAL BIOTECHNOLOGY MARKET, BY TYPE, 2025–2030 (USD MILLION)
TABLE 202 FRANCE: ANIMAL BIOTECHNOLOGY MARKET, BY APPLICATION, 2020–2024 (USD MILLION)
TABLE 203 FRANCE: ANIMAL BIOTECHNOLOGY MARKET, BY APPLICATION, 2025–2030 (USD MILLION)
TABLE 204 FRANCE: MICROBIAL BIOTECHNOLOGY MARKET, BY TYPE, 2020–2024 (USD MILLION)
TABLE 205 FRANCE: MICROBIAL BIOTECHNOLOGY MARKET, BY TYPE, 2025–2030 (USD MILLION)
TABLE 206 FRANCE: MICROBIAL BIOTECHNOLOGY MARKET, BY APPLICATION, 2020–2024 (USD MILLION)
TABLE 207 FRANCE: MICROBIAL BIOTECHNOLOGY MARKET, BY APPLICATION, 2025–2030 (USD MILLION)
TABLE 208 SPAIN: PLANT BIOTECHNOLOGY MARKET, BY TYPE, 2020–2024 (USD MILLION)
TABLE 209 SPAIN: PLANT BIOTECHNOLOGY MARKET, BY TYPE, 2025–2030 (USD MILLION)
TABLE 210 SPAIN: PLANT BIOTECHNOLOGY MARKET, BY APPLICATION, 2020–2024 (USD MILLION)
TABLE 211 SPAIN: PLANT BIOTECHNOLOGY MARKET, BY APPLICATION, 2025–2030 (USD MILLION)
TABLE 212 SPAIN: ANIMAL BIOTECHNOLOGY MARKET, BY TYPE, 2020–2024 (USD MILLION)
TABLE 213 SPAIN: ANIMAL BIOTECHNOLOGY MARKET, BY TYPE, 2025–2030 (USD MILLION)
TABLE 214 SPAIN: ANIMAL BIOTECHNOLOGY MARKET, BY APPLICATION, 2020–2024 (USD MILLION)
TABLE 215 SPAIN: ANIMAL BIOTECHNOLOGY MARKET, BY APPLICATION, 2025–2030 (USD MILLION)
TABLE 216 SPAIN: MICROBIAL BIOTECHNOLOGY MARKET, BY TYPE, 2020–2024 (USD MILLION)
TABLE 217 SPAIN: MICROBIAL BIOTECHNOLOGY MARKET, BY TYPE, 2025–2030 (USD MILLION)
TABLE 218 SPAIN: MICROBIAL BIOTECHNOLOGY MARKET, BY APPLICATION, 2020–2024 (USD MILLION)
TABLE 219 SPAIN: MICROBIAL BIOTECHNOLOGY MARKET, BY APPLICATION, 2025–2030 (USD MILLION)
TABLE 220 UK: PLANT BIOTECHNOLOGY MARKET, BY TYPE, 2020–2024 (USD MILLION)
TABLE 221 UK: PLANT BIOTECHNOLOGY MARKET, BY TYPE, 2025–2030 (USD MILLION)
TABLE 222 UK: PLANT BIOTECHNOLOGY MARKET, BY APPLICATION, 2020–2024 (USD MILLION)
TABLE 223 UK: PLANT BIOTECHNOLOGY MARKET, BY APPLICATION, 2025–2030 (USD MILLION)
TABLE 224 UK: ANIMAL BIOTECHNOLOGY MARKET, BY TYPE, 2020–2024 (USD MILLION)
TABLE 225 UK: ANIMAL BIOTECHNOLOGY MARKET, BY TYPE, 2025–2030 (USD MILLION)
TABLE 226 UK: ANIMAL BIOTECHNOLOGY MARKET, BY APPLICATION, 2020–2024 (USD MILLION)
TABLE 227 UK: ANIMAL BIOTECHNOLOGY MARKET, BY APPLICATION, 2025–2030 (USD MILLION)
TABLE 228 UK: MICROBIAL BIOTECHNOLOGY MARKET, BY TYPE, 2020–2024 (USD MILLION)
TABLE 229 UK: MICROBIAL BIOTECHNOLOGY MARKET, BY TYPE, 2025–2030 (USD MILLION)
TABLE 230 UK: MICROBIAL BIOTECHNOLOGY MARKET, BY APPLICATION, 2020–2024 (USD MILLION)
TABLE 231 UK: MICROBIAL BIOTECHNOLOGY MARKET, BY APPLICATION, 2025–2030 (USD MILLION)
TABLE 232 REST OF EUROPE: PLANT BIOTECHNOLOGY MARKET, BY TYPE, 2020–2024 (USD MILLION)
TABLE 233 REST OF EUROPE: PLANT BIOTECHNOLOGY MARKET, BY TYPE, 2025–2030 (USD MILLION)
TABLE 234 REST OF EUROPE: PLANT BIOTECHNOLOGY MARKET, BY APPLICATION, 2020–2024 (USD MILLION)
TABLE 235 REST OF EUROPE: PLANT BIOTECHNOLOGY MARKET, BY APPLICATION, 2025–2030 (USD MILLION)
TABLE 236 REST OF EUROPE: ANIMAL BIOTECHNOLOGY MARKET, BY TYPE, 2020–2024 (USD MILLION)
TABLE 237 REST OF EUROPE: ANIMAL BIOTECHNOLOGY MARKET, BY TYPE, 2025–2030 (USD MILLION)
TABLE 238 REST OF EUROPE: ANIMAL BIOTECHNOLOGY MARKET, BY APPLICATION, 2020–2024 (USD MILLION)
TABLE 239 REST OF EUROPE: ANIMAL BIOTECHNOLOGY MARKET, BY APPLICATION, 2025–2030 (USD MILLION)
TABLE 240 REST OF EUROPE: MICROBIAL BIOTECHNOLOGY MARKET, BY TYPE, 2020–2024 (USD MILLION)
TABLE 241 REST OF EUROPE: MICROBIAL BIOTECHNOLOGY MARKET, BY TYPE, 2025–2030 (USD MILLION)
TABLE 242 REST OF EUROPE: MICROBIAL BIOTECHNOLOGY MARKET, BY APPLICATION, 2020–2024 (USD MILLION)
TABLE 243 REST OF EUROPE: MICROBIAL BIOTECHNOLOGY MARKET, BY APPLICATION, 2025–2030 (USD MILLION)
TABLE 244 ASIA PACIFIC: AGRICULTURE BIOTECHNOLOGY MARKET, BY COUNTRY, 2020–2024 (USD MILLION)
TABLE 245 ASIA PACIFIC: AGRICULTURE BIOTECHNOLOGY MARKET, BY COUNTRY, 2025–2030 (USD MILLION)
TABLE 246 ASIA PACIFIC: PLANT BIOTECHNOLOGY MARKET, BY COUNTRY, 2020–2024 (USD MILLION)
TABLE 247 ASIA PACIFIC: PLANT BIOTECHNOLOGY MARKET, BY COUNTRY, 2025–2030 (USD MILLION)
TABLE 248 ASIA PACIFIC: PLANT BIOTECHNOLOGY MARKET, BY TYPE, 2020–2024 (USD MILLION)
TABLE 249 ASIA PACIFIC: PLANT BIOTECHNOLOGY MARKET, BY TYPE, 2025–2030 (USD MILLION)
TABLE 250 ASIA PACIFIC CROP PROTECTION & SOIL ENHANCEMENT PRODUCTS: PLANT BIOTECHNOLOGY MARKET, BY PRODUCT, 2020-2024 (THOUSAND METRIC TONS)
TABLE 251 ASIA PACIFIC CROP PROTECTION & SOIL ENHANCEMENT PRODUCTS: PLANT BIOTECHNOLOGY MARKET, BY PRODUCT, 2025-2030 (THOUSAND METRIC TONS)
TABLE 252 ASIA PACIFIC: PLANT BIOTECHNOLOGY MARKET, BY TECHNOLOGY, 2020–2024 (USD MILLION)
TABLE 253 ASIA PACIFIC: PLANT BIOTECHNOLOGY MARKET, BY TECHNOLOGY, 2025–2030 (USD MILLION)
TABLE 254 ASIA PACIFIC: PLANT BIOTECHNOLOGY MARKET, BY APPLICATION, 2020–2024 (USD MILLION)
TABLE 255 ASIA PACIFIC: PLANT BIOTECHNOLOGY MARKET, BY APPLICATION, 2025–2030 (USD MILLION)
TABLE 256 ASIA PACIFIC: ANIMAL BIOTECHNOLOGY MARKET, BY COUNTRY, 2020–2024 (USD MILLION)
TABLE 257 ASIA PACIFIC: ANIMAL BIOTECHNOLOGY MARKET, BY COUNTRY, 2025–2030 (USD MILLION)
TABLE 258 ASIA PACIFIC: ANIMAL BIOTECHNOLOGY MARKET, BY TYPE, 2020–2024 (USD MILLION)
TABLE 259 ASIA PACIFIC: ANIMAL BIOTECHNOLOGY MARKET, BY TYPE, 2025–2030 (USD MILLION)
TABLE 260 ASIA PACIFIC: ANIMAL BIOTECHNOLOGY MARKET, BY TECHNOLOGY, 2020–2024 (USD MILLION)
TABLE 261 ASIA PACIFIC: ANIMAL BIOTECHNOLOGY MARKET, BY TECHNOLOGY, 2025–2030 (USD MILLION)
TABLE 262 ASIA PACIFIC: ANIMAL BIOTECHNOLOGY MARKET, BY APPLICATION, 2020–2024 (USD MILLION)
TABLE 263 ASIA PACIFIC: ANIMAL BIOTECHNOLOGY MARKET, BY APPLICATION, 2025–2030 (USD MILLION)
TABLE 264 ASIA PACIFIC: MICROBIAL BIOTECHNOLOGY MARKET, BY COUNTRY, 2020–2024 (USD MILLION)
TABLE 265 ASIA PACIFIC: MICROBIAL BIOTECHNOLOGY MARKET, BY COUNTRY, 2025–2030 (USD MILLION)
TABLE 266 ASIA PACIFIC: MICROBIAL BIOTECHNOLOGY MARKET, BY TYPE, 2020–2024 (USD MILLION)
TABLE 267 ASIA PACIFIC: MICROBIAL BIOTECHNOLOGY MARKET, BY TYPE, 2025–2030 (USD MILLION)
TABLE 268 ASIA PACIFIC: MICROBIAL BIOTECHNOLOGY MARKET, BY TYPE, 2020-2024 (THOUSAND METRIC TONS)
TABLE 269 ASIA PACIFIC: MICROBIAL BIOTECHNOLOGY MARKET, BY TYPE, 2025-2030 (THOUSAND METRIC TONS)
TABLE 270 ASIA PACIFIC: MICROBIAL BIOTECHNOLOGY MARKET, BY TECHNOLOGY, 2020–2024 (USD MILLION)
TABLE 271 ASIA PACIFIC: MICROBIAL BIOTECHNOLOGY MARKET, BY TECHNOLOGY, 2025–2030 (USD MILLION)
TABLE 272 ASIA PACIFIC: MICROBIAL BIOTECHNOLOGY MARKET, BY APPLICATION, 2020–2024 (USD MILLION)
TABLE 273 ASIA PACIFIC: MICROBIAL BIOTECHNOLOGY MARKET, BY APPLICATION, 2025–2030 (USD MILLION)
TABLE 274 CHINA: PLANT BIOTECHNOLOGY MARKET, BY TYPE, 2020–2024 (USD MILLION)
TABLE 275 CHINA: PLANT BIOTECHNOLOGY MARKET, BY TYPE, 2025–2030 (USD MILLION)
TABLE 276 CHINA: PLANT BIOTECHNOLOGY MARKET, BY APPLICATION, 2020–2024 (USD MILLION)
TABLE 277 CHINA: PLANT BIOTECHNOLOGY MARKET, BY APPLICATION, 2025–2030 (USD MILLION)
TABLE 278 CHINA: ANIMAL BIOTECHNOLOGY MARKET, BY TYPE, 2020–2024 (USD MILLION)
TABLE 279 CHINA: ANIMAL BIOTECHNOLOGY MARKET, BY TYPE, 2025–2030 (USD MILLION)
TABLE 280 CHINA: ANIMAL BIOTECHNOLOGY MARKET, BY APPLICATION, 2020–2024 (USD MILLION)
TABLE 281 CHINA: ANIMAL BIOTECHNOLOGY MARKET, BY APPLICATION, 2025–2030 (USD MILLION)
TABLE 282 CHINA: MICROBIAL BIOTECHNOLOGY MARKET, BY TYPE, 2020–2024 (USD MILLION)
TABLE 283 CHINA: MICROBIAL BIOTECHNOLOGY MARKET, BY TYPE, 2025–2030 (USD MILLION)
TABLE 284 CHINA: MICROBIAL BIOTECHNOLOGY MARKET, BY APPLICATION, 2020–2024 (USD MILLION)
TABLE 285 CHINA: MICROBIAL BIOTECHNOLOGY MARKET, BY APPLICATION, 2025–2030 (USD MILLION)
TABLE 286 INDIA: PLANT BIOTECHNOLOGY MARKET, BY TYPE, 2020–2024 (USD MILLION)
TABLE 287 INDIA: PLANT BIOTECHNOLOGY MARKET, BY TYPE, 2025–2030 (USD MILLION)
TABLE 288 INDIA: PLANT BIOTECHNOLOGY MARKET, BY APPLICATION, 2020–2024 (USD MILLION)
TABLE 289 INDIA: PLANT BIOTECHNOLOGY MARKET, BY APPLICATION, 2025–2030 (USD MILLION)
TABLE 290 INDIA: ANIMAL BIOTECHNOLOGY MARKET, BY TYPE, 2020–2024 (USD MILLION)
TABLE 291 INDIA: ANIMAL BIOTECHNOLOGY MARKET, BY TYPE, 2025–2030 (USD MILLION)
TABLE 292 INDIA: ANIMAL BIOTECHNOLOGY MARKET, BY APPLICATION, 2020–2024 (USD MILLION)
TABLE 293 INDIA: ANIMAL BIOTECHNOLOGY MARKET, BY APPLICATION, 2025–2030 (USD MILLION)
TABLE 294 INDIA: MICROBIAL BIOTECHNOLOGY MARKET, BY TYPE, 2020–2024 (USD MILLION)
TABLE 295 INDIA: MICROBIAL BIOTECHNOLOGY MARKET, BY TYPE, 2025–2030 (USD MILLION)
TABLE 296 INDIA: MICROBIAL BIOTECHNOLOGY MARKET, BY APPLICATION, 2020–2024 (USD MILLION)
TABLE 297 INDIA: MICROBIAL BIOTECHNOLOGY MARKET, BY APPLICATION, 2025–2030 (USD MILLION)
TABLE 298 JAPAN: PLANT BIOTECHNOLOGY MARKET, BY TYPE, 2020–2024 (USD MILLION)
TABLE 299 JAPAN: PLANT BIOTECHNOLOGY MARKET, BY TYPE, 2025–2030 (USD MILLION)
TABLE 300 JAPAN: PLANT BIOTECHNOLOGY MARKET, BY APPLICATION, 2020–2024 (USD MILLION)
TABLE 301 JAPAN: PLANT BIOTECHNOLOGY MARKET, BY APPLICATION, 2025–2030 (USD MILLION)
TABLE 302 JAPAN: ANIMAL BIOTECHNOLOGY MARKET, BY TYPE, 2020–2024 (USD MILLION)
TABLE 303 JAPAN: ANIMAL BIOTECHNOLOGY MARKET, BY TYPE, 2025–2030 (USD MILLION)
TABLE 304 JAPAN: ANIMAL BIOTECHNOLOGY MARKET, BY APPLICATION, 2020–2024 (USD MILLION)
TABLE 305 JAPAN: ANIMAL BIOTECHNOLOGY MARKET, BY APPLICATION, 2025–2030 (USD MILLION)
TABLE 306 JAPAN: MICROBIAL BIOTECHNOLOGY MARKET, BY TYPE, 2020–2024 (USD MILLION)
TABLE 307 JAPAN: MICROBIAL BIOTECHNOLOGY MARKET, BY TYPE, 2025–2030 (USD MILLION)
TABLE 308 JAPAN: MICROBIAL BIOTECHNOLOGY MARKET, BY APPLICATION, 2020–2024 (USD MILLION)
TABLE 309 JAPAN: MICROBIAL BIOTECHNOLOGY MARKET, BY APPLICATION, 2025–2030 (USD MILLION)
TABLE 1 USD EXCHANGE RATES, 2020–2024
TABLE 2 AGRICULTURE BIOTECHNOLOGY MARKET SNAPSHOT, 2025 VS. 2030
TABLE 3 AGRICULTURE BIOTECHNOLOGY MARKET: PORTER’S FIVE FORCES ANALYSIS
TABLE 4 INDICATIVE PRICING ANALYSIS BY KEY COMPANIES FOR PLANT BIOTECHNOLOGY
TABLE 5 INDICATIVE PRICING ANALYSIS BY KEY COMPANIES FOR MICROBIAL BIOTECHNOLOGY
TABLE 6 INDICATIVE PRICING ANALYSIS BY KEY COMPANIES FOR ANIMAL BIOTECHNOLOGY
TABLE 7 PLANT BIOTECHNOLOGY – INDICATIVE REGIONAL PRICING, 2024
TABLE 8 MICROBIAL BIOTECHNOLOGY – INDICATIVE REGIONAL PRICING, 2024
TABLE 9 ANIMAL BIOTECHNOLOGY – INDICATIVE REGIONAL PRICING, 2024
TABLE 10 TOP 10 EXPORTERS OF HS CODE 382100, 2020–2024 (USD THOUSAND)
TABLE 11 TOP 10 IMPORTERS OF HS CODE 382100, 2020–2024 (USD THOUSAND)
TABLE 12 TOP 10 EXPORTERS OF HS CODE 382100, 2020–2024 (TONS)
TABLE 13 TOP 10 IMPORTERS OF HS CODE 382100, 2020–2024 (TONS)
TABLE 14 AGRICULTURE BIOTECHNOLOGY MARKET: DETAILED LIST OF CONFERENCES & EVENTS, 2025–2026
TABLE 15 US-ADJUSTED RECIPROCAL TARIFF RATES
TABLE 16 EXPECTED IMPACT LEVEL ON TARGET PRODUCTS WITH RELEVANT HS CODES DUE TO TRUMP TARIFF IMPACT
TABLE 17 EXPECTED TARIFF IMPACT ON END-USE INDUSTRIES
TABLE 18 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR AGRICULTURE BIOTECHNOLOGY TYPE
TABLE 19 KEY BUYING CRITERIA FOR AGRICULTURE BIOTECHNOLOGY MARKET, BY TYPE
TABLE 20 LIST OF MAJOR PATENTS FOR AGRICULTURE BIOTECHNOLOGY MARKET, 2021–2024
TABLE 21 NORTH AMERICA: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
TABLE 22 EUROPE: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
TABLE 23 ASIA PACIFIC: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
TABLE 24 SOUTH AMERICA: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
TABLE 25 MIDDLE EAST & AFRICA: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
TABLE 26 AGRICULTURE BIOTECHNOLOGY MARKET, BY TYPE OF ORGANISM, 2020–2024 (USD MILLION)
TABLE 27 AGRICULTURE BIOTECHNOLOGY MARKET, BY TYPE OF ORGANISM, 2025–2030 (USD MILLION)
TABLE 28 PLANTS: AGRICULTURE BIOTECHNOLOGY MARKET, BY REGION, 2020–2024 (USD MILLION)
TABLE 29 PLANTS: AGRICULTURE BIOTECHNOLOGY MARKET, BY REGION, 2025–2030 (USD MILLION)
TABLE 30 ANIMALS: AGRICULTURE BIOTECHNOLOGY MARKET, BY REGION, 2020–2024 (USD MILLION)
TABLE 31 ANIMALS: AGRICULTURE BIOTECHNOLOGY MARKET, BY REGION, 2025–2030 (USD MILLION)
TABLE 32 MICROBIAL: AGRICULTURE BIOTECHNOLOGY MARKET, BY REGION, 2020–2024 (USD MILLION)
TABLE 33 MICROBIAL: AGRICULTURE BIOTECHNOLOGY MARKET, BY REGION, 2025–2030 (USD MILLION)
TABLE 34 PLANT BIOTECHNOLOGY MARKET, BY TYPE, 2020–2024 (USD MILLION)
TABLE 35 PLANT BIOTECHNOLOGY MARKET, BY TYPE, 2025–2030 (USD MILLION)
TABLE 36 CROP PROTECTION & SOIL ENHANCEMENT: PLANT BIOTECHNOLOGY MARKET, BY PRODUCT, 2020-2024 (THOUSAND METRIC TONS)
TABLE 37 CROP PROTECTION & SOIL ENHANCEMENT: PLANT BIOTECHNOLOGY MARKET, BY PRODUCT, 2025-2030 (THOUSAND METRIC TONS)
TABLE 38 CROP PROTECTION & SOIL ENHANCEMENT: PLANT BIOTECHNOLOGY MARKET, BY REGION, 2020-2024 (THOUSAND METRIC TONS)
TABLE 39 CROP PROTECTION & SOIL ENHANCEMENT: PLANT BIOTECHNOLOGY MARKET, BY REGION, 2025-2030 (THOUSAND METRIC TONS)
TABLE 40 BIOPESTICIDES: PLANT BIOTECHNOLOGY MARKET, BY REGION, 2020-2024 (THOUSAND METRIC TONS)
TABLE 41 BIOPESTICIDES: PLANT BIOTECHNOLOGY MARKET, BY REGION, 2025-2030 (THOUSAND METRIC TONS)
TABLE 42 BIOFERTILIZERS: PLANT BIOTECHNOLOGY MARKET, BY REGION, 2020-2024 (THOUSAND METRIC TONS)
TABLE 43 BIOFERTILIZERS: PLANT BIOTECHNOLOGY MARKET, BY REGION, 2025-2030 (THOUSAND METRIC TONS)
TABLE 44 PLANT GROWTH REGULATORS: PLANT BIOTECHNOLOGY MARKET, BY REGION, 2020-2024 (THOUSAND METRIC TONS)
TABLE 45 PLANT GROWTH REGULATORS: PLANT BIOTECHNOLOGY MARKET, BY REGION, 2025-2030 (THOUSAND METRIC TONS)
TABLE 46 ANIMAL BIOTECHNOLOGY MARKET, BY TYPE, 2020–2024 (USD MILLION)
TABLE 47 ANIMAL BIOTECHNOLOGY MARKET, BY TYPE, 2025–2030 (USD MILLION)
TABLE 48 MICROBIAL BIOTECHNOLOGY MARKET, BY TYPE, 2020–2024 (USD MILLION)
TABLE 49 MICROBIAL BIOTECHNOLOGY MARKET, BY TYPE, 2025–2030 (USD MILLION)
TABLE 50 MICROBIAL BIOTECHNOLOGY MARKET, BY TYPE, 2020-2024 (THOUSAND METRIC TONS)
TABLE 51 MICROBIAL BIOTECHNOLOGY MARKET, BY TYPE, 2025-2030 (THOUSAND METRIC TONS)
TABLE 52 MICROBIAL BIOFERTILIZERS & MICROBIAL BIOSTIMULANTS: AGRICULTURAL MICROBIALS MARKET, BY REGION, 2020-2024 (THOUSAND METRIC TONS)
TABLE 53 MICROBIAL BIOFERTILIZERS & MICROBIAL BIOSTIMULANTS: AGRICULTURAL MICROBIALS MARKET, BY REGION, 2025-2030 (THOUSAND METRIC TONS)
TABLE 54 MICROBIAL BIOCONTROL AGENTS: AGRICULTURAL MICROBIALS MARKET, BY REGION, 2020-2024 (THOUSAND METRIC TONS)
TABLE 55 MICROBIAL BIOCONTROL AGENTS: AGRICULTURAL MICROBIALS MARKET, BY REGION, 2025-2030 (THOUSAND METRIC TONS)
TABLE 56 PLANT BIOTECHNOLOGY MARKET, BY APPLICATION, 2020–2024 (USD MILLION)
TABLE 57 PLANT BIOTECHNOLOGY MARKET, BY APPLICATION, 2025–2030 (USD MILLION)
TABLE 58 ANIMAL BIOTECHNOLOGY MARKET, BY APPLICATION, 2020–2024 (USD MILLION)
TABLE 59 ANIMAL BIOTECHNOLOGY MARKET, BY APPLICATION, 2025–2030 (USD MILLION)
TABLE 60 MICROBIAL BIOTECHNOLOGY MARKET, BY APPLICATION, 2020–2024 (USD MILLION)
TABLE 61 MICROBIAL BIOTECHNOLOGY MARKET, BY APPLICATION, 2025–2030 (USD MILLION)
TABLE 62 PLANT BIOTECHNOLOGY MARKET, BY TECHNOLOGY, 2020–2024 (USD MILLION)
TABLE 63 PLANT BIOTECHNOLOGY MARKET, BY TECHNOLOGY, 2025–2030 (USD MILLION)
TABLE 64 ANIMAL BIOTECHNOLOGY MARKET, BY TECHNOLOGY, 2020–2024 (USD MILLION)
TABLE 65 ANIMAL BIOTECHNOLOGY MARKET, BY TECHNOLOGY, 2025–2030 (USD MILLION)
TABLE 66 MICROBIAL BIOTECHNOLOGY MARKET, BY TECHNOLOGY, 2020–2024 (USD MILLION)
TABLE 67 MICROBIAL BIOTECHNOLOGY MARKET, BY TECHNOLOGY, 2025–2030 (USD MILLION)
TABLE 68 AGRICULTURE BIOTECHNOLOGY MARKET, BY REGION, 2020–2024 (USD MILLION)
TABLE 69 AGRICULTURE BIOTECHNOLOGY MARKET, BY REGION, 2025–2030 (USD MILLION)
TABLE 70 PLANT BIOTECHNOLOGY MARKET, BY REGION, 2020–2024 (USD MILLION)
TABLE 71 PLANT BIOTECHNOLOGY MARKET, BY REGION, 2025–2030 (USD MILLION)
TABLE 72 ANIMAL BIOTECHNOLOGY MARKET, BY REGION, 2020–2024 (USD MILLION)
TABLE 73 ANIMAL BIOTECHNOLOGY MARKET, BY REGION, 2025–2030 (USD MILLION)
TABLE 74 MICROBIAL BIOTECHNOLOGY MARKET, BY REGION, 2020–2024 (USD MILLION)
TABLE 75 MICROBIAL BIOTECHNOLOGY MARKET, BY REGION, 2025–2030 (USD MILLION)
TABLE 76 NORTH AMERICA: AGRICULTURE BIOTECHNOLOGY MARKET, BY COUNTRY, 2020–2024 (USD MILLION)
TABLE 77 NORTH AMERICA: AGRICULTURE BIOTECHNOLOGY MARKET, BY COUNTRY, 2025–2030 (USD MILLION)
TABLE 78 NORTH AMERICA: PLANT BIOTECHNOLOGY MARKET, BY COUNTRY, 2020–2024 (USD MILLION)
TABLE 79 NORTH AMERICA: PLANT BIOTECHNOLOGY MARKET, BY COUNTRY, 2025–2030 (USD MILLION)
TABLE 80 NORTH AMERICA: PLANT BIOTECHNOLOGY MARKET, BY TYPE, 2020–2024 (USD MILLION)
TABLE 81 NORTH AMERICA: PLANT BIOTECHNOLOGY MARKET, BY TYPE, 2025–2030 (USD MILLION)
TABLE 82 NORTH AMERICAN CROP PROTECTION & SOIL ENHANCEMENT PRODUCTS: PLANT BIOTECHNOLOGY MARKET, BY PRODUCT, 2020-2024 (THOUSAND METRIC TONS)
TABLE 83 NORTH AMERICAN CROP PROTECTION & SOIL ENHANCEMENT PRODUCTS: PLANT BIOTECHNOLOGY MARKET, BY PRODUCT, 2025-2030 (THOUSAND METRIC TONS)
TABLE 84 NORTH AMERICA: PLANT BIOTECHNOLOGY MARKET, BY TECHNOLOGY, 2020–2024 (USD MILLION)
TABLE 85 NORTH AMERICA: PLANT BIOTECHNOLOGY MARKET, BY TECHNOLOGY, 2025–2030 (USD MILLION)
TABLE 86 NORTH AMERICA: PLANT BIOTECHNOLOGY MARKET, BY APPLICATION, 2020–2024 (USD MILLION)
TABLE 87 NORTH AMERICA: PLANT BIOTECHNOLOGY MARKET, BY APPLICATION, 2025–2030 (USD MILLION)
TABLE 88 NORTH AMERICA: ANIMAL BIOTECHNOLOGY MARKET, BY COUNTRY, 2020–2024 (USD MILLION)
TABLE 89 NORTH AMERICA: ANIMAL BIOTECHNOLOGY MARKET, BY COUNTRY, 2025–2030 (USD MILLION)
TABLE 90 NORTH AMERICA: ANIMAL BIOTECHNOLOGY MARKET, BY TYPE, 2020–2024 (USD MILLION)
TABLE 91 NORTH AMERICA: ANIMAL BIOTECHNOLOGY MARKET, BY TYPE, 2025–2030 (USD MILLION)
TABLE 92 NORTH AMERICA: ANIMAL BIOTECHNOLOGY MARKET, BY TECHNOLOGY, 2020–2024 (USD MILLION)
TABLE 93 NORTH AMERICA: ANIMAL BIOTECHNOLOGY MARKET, BY TECHNOLOGY, 2025–2030 (USD MILLION)
TABLE 94 NORTH AMERICA: ANIMAL BIOTECHNOLOGY MARKET, BY APPLICATION, 2020–2024 (USD MILLION)
TABLE 95 NORTH AMERICA: ANIMAL BIOTECHNOLOGY MARKET, BY APPLICATION, 2025–2030 (USD MILLION)
TABLE 96 NORTH AMERICA: MICROBIAL BIOTECHNOLOGY MARKET, BY COUNTRY, 2020–2024 (USD MILLION)
TABLE 97 NORTH AMERICA: MICROBIAL BIOTECHNOLOGY MARKET, BY COUNTRY, 2025–2030 (USD MILLION)
TABLE 98 NORTH AMERICA: MICROBIAL BIOTECHNOLOGY MARKET, BY TYPE, 2020–2024 (USD MILLION)
TABLE 99 NORTH AMERICA: MICROBIAL BIOTECHNOLOGY MARKET, BY TYPE, 2025–2030 (USD MILLION)
TABLE 100 NORTH AMERICA: MICROBIAL BIOTECHNOLOGY MARKET, BY TYPE, 2020-2024 (THOUSAND METRIC TONS)
TABLE 101 NORTH AMERICA: MICROBIAL BIOTECHNOLOGY MARKET, BY TYPE, 2025-2030 (THOUSAND METRIC TONS)
TABLE 102 NORTH AMERICA: MICROBIAL BIOTECHNOLOGY MARKET, BY TECHNOLOGY, 2020–2024 (USD MILLION)
TABLE 103 NORTH AMERICA: MICROBIAL BIOTECHNOLOGY MARKET, BY TECHNOLOGY, 2025–2030 (USD MILLION)
TABLE 104 NORTH AMERICA: MICROBIAL BIOTECHNOLOGY MARKET, BY APPLICATION, 2020–2024 (USD MILLION)
TABLE 105 NORTH AMERICA: MICROBIAL BIOTECHNOLOGY MARKET, BY APPLICATION, 2025–2030 (USD MILLION)
TABLE 106 US: PLANT BIOTECHNOLOGY MARKET, BY TYPE, 2020–2024 (USD MILLION)
TABLE 107 US: PLANT BIOTECHNOLOGY MARKET, BY TYPE, 2025–2030 (USD MILLION)
TABLE 108 US: PLANT BIOTECHNOLOGY MARKET, BY APPLICATION, 2020–2024 (USD MILLION)
TABLE 109 US: PLANT BIOTECHNOLOGY MARKET, BY APPLICATION, 2025–2030 (USD MILLION)
TABLE 110 US: ANIMAL BIOTECHNOLOGY MARKET, BY TYPE, 2020–2024 (USD MILLION)
TABLE 111 US: ANIMAL BIOTECHNOLOGY MARKET, BY TYPE, 2025–2030 (USD MILLION)
TABLE 112 US: ANIMAL BIOTECHNOLOGY MARKET, BY APPLICATION, 2020–2024 (USD MILLION)
TABLE 113 US: ANIMAL BIOTECHNOLOGY MARKET, BY APPLICATION, 2025–2030 (USD MILLION)
TABLE 114 US: MICROBIAL BIOTECHNOLOGY MARKET, BY TYPE, 2020–2024 (USD MILLION)
TABLE 115 US: MICROBIAL BIOTECHNOLOGY MARKET, BY TYPE, 2025–2030 (USD MILLION)
TABLE 116 US: MICROBIAL BIOTECHNOLOGY MARKET, BY APPLICATION, 2020–2024 (USD MILLION)
TABLE 117 US: MICROBIAL BIOTECHNOLOGY MARKET, BY APPLICATION, 2025–2030 (USD MILLION)
TABLE 118 CANADA: PLANT BIOTECHNOLOGY MARKET, BY TYPE, 2020–2024 (USD MILLION)
TABLE 119 CANADA: PLANT BIOTECHNOLOGY MARKET, BY TYPE, 2025–2030 (USD MILLION)
TABLE 120 CANADA: PLANT BIOTECHNOLOGY MARKET, BY APPLICATION, 2020–2024 (USD MILLION)
TABLE 121 CANADA: PLANT BIOTECHNOLOGY MARKET, BY APPLICATION, 2025–2030 (USD MILLION)
TABLE 122 CANADA: ANIMAL BIOTECHNOLOGY MARKET, BY TYPE, 2020–2024 (USD MILLION)
TABLE 123 CANADA: ANIMAL BIOTECHNOLOGY MARKET, BY TYPE, 2025–2030 (USD MILLION)
TABLE 124 CANADA: ANIMAL BIOTECHNOLOGY MARKET, BY APPLICATION, 2020–2024 (USD MILLION)
TABLE 125 CANADA: ANIMAL BIOTECHNOLOGY MARKET, BY APPLICATION, 2025–2030 (USD MILLION)
TABLE 126 CANADA: MICROBIAL BIOTECHNOLOGY MARKET, BY TYPE, 2020–2024 (USD MILLION)
TABLE 127 CANADA: MICROBIAL BIOTECHNOLOGY MARKET, BY TYPE, 2025–2030 (USD MILLION)
TABLE 128 CANADA: MICROBIAL BIOTECHNOLOGY MARKET, BY APPLICATION, 2020–2024 (USD MILLION)
TABLE 129 CANADA: MICROBIAL BIOTECHNOLOGY MARKET, BY APPLICATION, 2025–2030 (USD MILLION)
TABLE 130 MEXICO: PLANT BIOTECHNOLOGY MARKET, BY TYPE, 2020–2024 (USD MILLION)
TABLE 131 MEXICO: PLANT BIOTECHNOLOGY MARKET, BY TYPE, 2025–2030 (USD MILLION)
TABLE 132 MEXICO: PLANT BIOTECHNOLOGY MARKET, BY APPLICATION, 2020–2024 (USD MILLION)
TABLE 133 MEXICO: PLANT BIOTECHNOLOGY MARKET, BY APPLICATION, 2025–2030 (USD MILLION)
TABLE 134 MEXICO: ANIMAL BIOTECHNOLOGY MARKET, BY TYPE, 2020–2024 (USD MILLION)
TABLE 135 MEXICO: ANIMAL BIOTECHNOLOGY MARKET, BY TYPE, 2025–2030 (USD MILLION)
TABLE 136 MEXICO: ANIMAL BIOTECHNOLOGY MARKET, BY APPLICATION, 2020–2024 (USD MILLION)
TABLE 137 MEXICO: ANIMAL BIOTECHNOLOGY MARKET, BY APPLICATION, 2025–2030 (USD MILLION)
TABLE 138 MEXICO: MICROBIAL BIOTECHNOLOGY MARKET, BY TYPE, 2020–2024 (USD MILLION)
TABLE 139 MEXICO: MICROBIAL BIOTECHNOLOGY MARKET, BY TYPE, 2025–2030 (USD MILLION)
TABLE 140 MEXICO: MICROBIAL BIOTECHNOLOGY MARKET, BY APPLICATION, 2020–2024 (USD MILLION)
TABLE 141 MEXICO: MICROBIAL BIOTECHNOLOGY MARKET, BY APPLICATION, 2025–2030 (USD MILLION)
TABLE 142 EUROPE: AGRICULTURE BIOTECHNOLOGY MARKET, BY COUNTRY, 2020–2024 (USD MILLION)
TABLE 143 EUROPE: AGRICULTURE BIOTECHNOLOGY MARKET, BY COUNTRY, 2025–2030 (USD MILLION)
TABLE 144 EUROPE: PLANT BIOTECHNOLOGY MARKET, BY COUNTRY, 2020–2024 (USD MILLION)
TABLE 145 EUROPE: PLANT BIOTECHNOLOGY MARKET, BY COUNTRY, 2025–2030 (USD MILLION)
TABLE 146 EUROPE: PLANT BIOTECHNOLOGY MARKET, BY TYPE, 2020–2024 (USD MILLION)
TABLE 147 EUROPE: PLANT BIOTECHNOLOGY MARKET, BY TYPE, 2025–2030 (USD MILLION)
TABLE 148 EUROPEAN CROP PROTECTION & SOIL ENHANCEMENT PRODUCTS: PLANT BIOTECHNOLOGY MARKET, BY PRODUCT, 2020-2024 (THOUSAND METRIC TONS)
TABLE 149 EUROPEAN CROP PROTECTION & SOIL ENHANCEMENT PRODUCTS: PLANT BIOTECHNOLOGY MARKET, BY PRODUCT, 2025-2030 (THOUSAND METRIC TONS)
TABLE 150 EUROPE: PLANT BIOTECHNOLOGY MARKET, BY TECHNOLOGY, 2020–2024 (USD MILLION)
TABLE 151 EUROPE: PLANT BIOTECHNOLOGY MARKET, BY TECHNOLOGY, 2025–2030 (USD MILLION)
TABLE 152 EUROPE: PLANT BIOTECHNOLOGY MARKET, BY APPLICATION, 2020–2024 (USD MILLION)
TABLE 153 EUROPE: PLANT BIOTECHNOLOGY MARKET, BY APPLICATION, 2025–2030 (USD MILLION)
TABLE 154 EUROPE: ANIMAL BIOTECHNOLOGY MARKET, BY COUNTRY, 2020–2024 (USD MILLION)
TABLE 155 EUROPE: ANIMAL BIOTECHNOLOGY MARKET, BY COUNTRY, 2025–2030 (USD MILLION)
TABLE 156 EUROPE: ANIMAL BIOTECHNOLOGY MARKET, BY TYPE, 2020–2024 (USD MILLION)
TABLE 157 EUROPE: ANIMAL BIOTECHNOLOGY MARKET, BY TYPE, 2025–2030 (USD MILLION)
TABLE 158 EUROPE: ANIMAL BIOTECHNOLOGY MARKET, BY TECHNOLOGY, 2020–2024 (USD MILLION)
TABLE 159 EUROPE: ANIMAL BIOTECHNOLOGY MARKET, BY TECHNOLOGY, 2025–2030 (USD MILLION)
TABLE 160 EUROPE: ANIMAL BIOTECHNOLOGY MARKET, BY APPLICATION, 2020–2024 (USD MILLION)
TABLE 161 EUROPE: ANIMAL BIOTECHNOLOGY MARKET, BY APPLICATION, 2025–2030 (USD MILLION)
TABLE 162 EUROPE: MICROBIAL BIOTECHNOLOGY MARKET, BY COUNTRY, 2020–2024 (USD MILLION)
TABLE 163 EUROPE: MICROBIAL BIOTECHNOLOGY MARKET, BY COUNTRY, 2025–2030 (USD MILLION)
TABLE 164 EUROPE: MICROBIAL BIOTECHNOLOGY MARKET, BY TYPE, 2020–2024 (USD MILLION)
TABLE 165 EUROPE: MICROBIAL BIOTECHNOLOGY MARKET, BY TYPE, 2025–2030 (USD MILLION)
TABLE 166 EUROPE: MICROBIAL BIOTECHNOLOGY MARKET, BY TYPE, 2020-2024 (THOUSAND METRIC TONS)
TABLE 167 EUROPE: MICROBIAL BIOTECHNOLOGY MARKET, BY TYPE, 2025-2030 (THOUSAND METRIC TONS)
TABLE 168 EUROPE: MICROBIAL BIOTECHNOLOGY MARKET, BY TECHNOLOGY, 2020–2024 (USD MILLION)
TABLE 169 EUROPE: MICROBIAL BIOTECHNOLOGY MARKET, BY TECHNOLOGY, 2025–2030 (USD MILLION)
TABLE 170 EUROPE: MICROBIAL BIOTECHNOLOGY MARKET, BY APPLICATION, 2020–2024 (USD MILLION)
TABLE 171 EUROPE: MICROBIAL BIOTECHNOLOGY MARKET, BY APPLICATION, 2025–2030 (USD MILLION)
TABLE 172 GERMANY: PLANT BIOTECHNOLOGY MARKET, BY TYPE, 2020–2024 (USD MILLION)
TABLE 173 GERMANY: PLANT BIOTECHNOLOGY MARKET, BY TYPE, 2025–2030 (USD MILLION)
TABLE 174 GERMANY: PLANT BIOTECHNOLOGY MARKET, BY APPLICATION, 2020–2024 (USD MILLION)
TABLE 175 GERMANY: PLANT BIOTECHNOLOGY MARKET, BY APPLICATION, 2025–2030 (USD MILLION)
TABLE 176 GERMANY: ANIMAL BIOTECHNOLOGY MARKET, BY TYPE, 2020–2024 (USD MILLION)
TABLE 177 GERMANY: ANIMAL BIOTECHNOLOGY MARKET, BY TYPE, 2025–2030 (USD MILLION)
TABLE 178 GERMANY: ANIMAL BIOTECHNOLOGY MARKET, BY APPLICATION, 2020–2024 (USD MILLION)
TABLE 179 GERMANY: ANIMAL BIOTECHNOLOGY MARKET, BY APPLICATION, 2025–2030 (USD MILLION)
TABLE 180 GERMANY: MICROBIAL BIOTECHNOLOGY MARKET, BY TYPE, 2020–2024 (USD MILLION)
TABLE 181 GERMANY: MICROBIAL BIOTECHNOLOGY MARKET, BY TYPE, 2025–2030 (USD MILLION)
TABLE 182 GERMANY: MICROBIAL BIOTECHNOLOGY MARKET, BY APPLICATION, 2020–2024 (USD MILLION)
TABLE 183 GERMANY: MICROBIAL BIOTECHNOLOGY MARKET, BY APPLICATION, 2025–2030 (USD MILLION)
TABLE 184 ITALY: PLANT BIOTECHNOLOGY MARKET, BY TYPE, 2020–2024 (USD MILLION)
TABLE 185 ITALY: PLANT BIOTECHNOLOGY MARKET, BY TYPE, 2025–2030 (USD MILLION)
TABLE 186 ITALY: PLANT BIOTECHNOLOGY MARKET, BY APPLICATION, 2020–2024 (USD MILLION)
TABLE 187 ITALY: PLANT BIOTECHNOLOGY MARKET, BY APPLICATION, 2025–2030 (USD MILLION)
TABLE 188 ITALY: ANIMAL BIOTECHNOLOGY MARKET, BY TYPE, 2020–2024 (USD MILLION)
TABLE 189 ITALY: ANIMAL BIOTECHNOLOGY MARKET, BY TYPE, 2025–2030 (USD MILLION)
TABLE 190 ITALY: ANIMAL BIOTECHNOLOGY MARKET, BY APPLICATION, 2020–2024 (USD MILLION)
TABLE 191 ITALY: ANIMAL BIOTECHNOLOGY MARKET, BY APPLICATION, 2025–2030 (USD MILLION)
TABLE 192 ITALY: MICROBIAL BIOTECHNOLOGY MARKET, BY TYPE, 2020–2024 (USD MILLION)
TABLE 193 ITALY: MICROBIAL BIOTECHNOLOGY MARKET, BY TYPE, 2025–2030 (USD MILLION)
TABLE 194 ITALY: MICROBIAL BIOTECHNOLOGY MARKET, BY APPLICATION, 2020–2024 (USD MILLION)
TABLE 195 ITALY: MICROBIAL BIOTECHNOLOGY MARKET, BY APPLICATION, 2025–2030 (USD MILLION)
TABLE 196 FRANCE: PLANT BIOTECHNOLOGY MARKET, BY TYPE, 2020–2024 (USD MILLION)
TABLE 197 FRANCE: PLANT BIOTECHNOLOGY MARKET, BY TYPE, 2025–2030 (USD MILLION)
TABLE 198 FRANCE: PLANT BIOTECHNOLOGY MARKET, BY APPLICATION, 2020–2024 (USD MILLION)
TABLE 199 FRANCE: PLANT BIOTECHNOLOGY MARKET, BY APPLICATION, 2025–2030 (USD MILLION)
TABLE 200 FRANCE: ANIMAL BIOTECHNOLOGY MARKET, BY TYPE, 2020–2024 (USD MILLION)
TABLE 201 FRANCE: ANIMAL BIOTECHNOLOGY MARKET, BY TYPE, 2025–2030 (USD MILLION)
TABLE 202 FRANCE: ANIMAL BIOTECHNOLOGY MARKET, BY APPLICATION, 2020–2024 (USD MILLION)
TABLE 203 FRANCE: ANIMAL BIOTECHNOLOGY MARKET, BY APPLICATION, 2025–2030 (USD MILLION)
TABLE 204 FRANCE: MICROBIAL BIOTECHNOLOGY MARKET, BY TYPE, 2020–2024 (USD MILLION)
TABLE 205 FRANCE: MICROBIAL BIOTECHNOLOGY MARKET, BY TYPE, 2025–2030 (USD MILLION)
TABLE 206 FRANCE: MICROBIAL BIOTECHNOLOGY MARKET, BY APPLICATION, 2020–2024 (USD MILLION)
TABLE 207 FRANCE: MICROBIAL BIOTECHNOLOGY MARKET, BY APPLICATION, 2025–2030 (USD MILLION)
TABLE 208 SPAIN: PLANT BIOTECHNOLOGY MARKET, BY TYPE, 2020–2024 (USD MILLION)
TABLE 209 SPAIN: PLANT BIOTECHNOLOGY MARKET, BY TYPE, 2025–2030 (USD MILLION)
TABLE 210 SPAIN: PLANT BIOTECHNOLOGY MARKET, BY APPLICATION, 2020–2024 (USD MILLION)
TABLE 211 SPAIN: PLANT BIOTECHNOLOGY MARKET, BY APPLICATION, 2025–2030 (USD MILLION)
TABLE 212 SPAIN: ANIMAL BIOTECHNOLOGY MARKET, BY TYPE, 2020–2024 (USD MILLION)
TABLE 213 SPAIN: ANIMAL BIOTECHNOLOGY MARKET, BY TYPE, 2025–2030 (USD MILLION)
TABLE 214 SPAIN: ANIMAL BIOTECHNOLOGY MARKET, BY APPLICATION, 2020–2024 (USD MILLION)
TABLE 215 SPAIN: ANIMAL BIOTECHNOLOGY MARKET, BY APPLICATION, 2025–2030 (USD MILLION)
TABLE 216 SPAIN: MICROBIAL BIOTECHNOLOGY MARKET, BY TYPE, 2020–2024 (USD MILLION)
TABLE 217 SPAIN: MICROBIAL BIOTECHNOLOGY MARKET, BY TYPE, 2025–2030 (USD MILLION)
TABLE 218 SPAIN: MICROBIAL BIOTECHNOLOGY MARKET, BY APPLICATION, 2020–2024 (USD MILLION)
TABLE 219 SPAIN: MICROBIAL BIOTECHNOLOGY MARKET, BY APPLICATION, 2025–2030 (USD MILLION)
TABLE 220 UK: PLANT BIOTECHNOLOGY MARKET, BY TYPE, 2020–2024 (USD MILLION)
TABLE 221 UK: PLANT BIOTECHNOLOGY MARKET, BY TYPE, 2025–2030 (USD MILLION)
TABLE 222 UK: PLANT BIOTECHNOLOGY MARKET, BY APPLICATION, 2020–2024 (USD MILLION)
TABLE 223 UK: PLANT BIOTECHNOLOGY MARKET, BY APPLICATION, 2025–2030 (USD MILLION)
TABLE 224 UK: ANIMAL BIOTECHNOLOGY MARKET, BY TYPE, 2020–2024 (USD MILLION)
TABLE 225 UK: ANIMAL BIOTECHNOLOGY MARKET, BY TYPE, 2025–2030 (USD MILLION)
TABLE 226 UK: ANIMAL BIOTECHNOLOGY MARKET, BY APPLICATION, 2020–2024 (USD MILLION)
TABLE 227 UK: ANIMAL BIOTECHNOLOGY MARKET, BY APPLICATION, 2025–2030 (USD MILLION)
TABLE 228 UK: MICROBIAL BIOTECHNOLOGY MARKET, BY TYPE, 2020–2024 (USD MILLION)
TABLE 229 UK: MICROBIAL BIOTECHNOLOGY MARKET, BY TYPE, 2025–2030 (USD MILLION)
TABLE 230 UK: MICROBIAL BIOTECHNOLOGY MARKET, BY APPLICATION, 2020–2024 (USD MILLION)
TABLE 231 UK: MICROBIAL BIOTECHNOLOGY MARKET, BY APPLICATION, 2025–2030 (USD MILLION)
TABLE 232 REST OF EUROPE: PLANT BIOTECHNOLOGY MARKET, BY TYPE, 2020–2024 (USD MILLION)
TABLE 233 REST OF EUROPE: PLANT BIOTECHNOLOGY MARKET, BY TYPE, 2025–2030 (USD MILLION)
TABLE 234 REST OF EUROPE: PLANT BIOTECHNOLOGY MARKET, BY APPLICATION, 2020–2024 (USD MILLION)
TABLE 235 REST OF EUROPE: PLANT BIOTECHNOLOGY MARKET, BY APPLICATION, 2025–2030 (USD MILLION)
TABLE 236 REST OF EUROPE: ANIMAL BIOTECHNOLOGY MARKET, BY TYPE, 2020–2024 (USD MILLION)
TABLE 237 REST OF EUROPE: ANIMAL BIOTECHNOLOGY MARKET, BY TYPE, 2025–2030 (USD MILLION)
TABLE 238 REST OF EUROPE: ANIMAL BIOTECHNOLOGY MARKET, BY APPLICATION, 2020–2024 (USD MILLION)
TABLE 239 REST OF EUROPE: ANIMAL BIOTECHNOLOGY MARKET, BY APPLICATION, 2025–2030 (USD MILLION)
TABLE 240 REST OF EUROPE: MICROBIAL BIOTECHNOLOGY MARKET, BY TYPE, 2020–2024 (USD MILLION)
TABLE 241 REST OF EUROPE: MICROBIAL BIOTECHNOLOGY MARKET, BY TYPE, 2025–2030 (USD MILLION)
TABLE 242 REST OF EUROPE: MICROBIAL BIOTECHNOLOGY MARKET, BY APPLICATION, 2020–2024 (USD MILLION)
TABLE 243 REST OF EUROPE: MICROBIAL BIOTECHNOLOGY MARKET, BY APPLICATION, 2025–2030 (USD MILLION)
TABLE 244 ASIA PACIFIC: AGRICULTURE BIOTECHNOLOGY MARKET, BY COUNTRY, 2020–2024 (USD MILLION)
TABLE 245 ASIA PACIFIC: AGRICULTURE BIOTECHNOLOGY MARKET, BY COUNTRY, 2025–2030 (USD MILLION)
TABLE 246 ASIA PACIFIC: PLANT BIOTECHNOLOGY MARKET, BY COUNTRY, 2020–2024 (USD MILLION)
TABLE 247 ASIA PACIFIC: PLANT BIOTECHNOLOGY MARKET, BY COUNTRY, 2025–2030 (USD MILLION)
TABLE 248 ASIA PACIFIC: PLANT BIOTECHNOLOGY MARKET, BY TYPE, 2020–2024 (USD MILLION)
TABLE 249 ASIA PACIFIC: PLANT BIOTECHNOLOGY MARKET, BY TYPE, 2025–2030 (USD MILLION)
TABLE 250 ASIA PACIFIC CROP PROTECTION & SOIL ENHANCEMENT PRODUCTS: PLANT BIOTECHNOLOGY MARKET, BY PRODUCT, 2020-2024 (THOUSAND METRIC TONS)
TABLE 251 ASIA PACIFIC CROP PROTECTION & SOIL ENHANCEMENT PRODUCTS: PLANT BIOTECHNOLOGY MARKET, BY PRODUCT, 2025-2030 (THOUSAND METRIC TONS)
TABLE 252 ASIA PACIFIC: PLANT BIOTECHNOLOGY MARKET, BY TECHNOLOGY, 2020–2024 (USD MILLION)
TABLE 253 ASIA PACIFIC: PLANT BIOTECHNOLOGY MARKET, BY TECHNOLOGY, 2025–2030 (USD MILLION)
TABLE 254 ASIA PACIFIC: PLANT BIOTECHNOLOGY MARKET, BY APPLICATION, 2020–2024 (USD MILLION)
TABLE 255 ASIA PACIFIC: PLANT BIOTECHNOLOGY MARKET, BY APPLICATION, 2025–2030 (USD MILLION)
TABLE 256 ASIA PACIFIC: ANIMAL BIOTECHNOLOGY MARKET, BY COUNTRY, 2020–2024 (USD MILLION)
TABLE 257 ASIA PACIFIC: ANIMAL BIOTECHNOLOGY MARKET, BY COUNTRY, 2025–2030 (USD MILLION)
TABLE 258 ASIA PACIFIC: ANIMAL BIOTECHNOLOGY MARKET, BY TYPE, 2020–2024 (USD MILLION)
TABLE 259 ASIA PACIFIC: ANIMAL BIOTECHNOLOGY MARKET, BY TYPE, 2025–2030 (USD MILLION)
TABLE 260 ASIA PACIFIC: ANIMAL BIOTECHNOLOGY MARKET, BY TECHNOLOGY, 2020–2024 (USD MILLION)
TABLE 261 ASIA PACIFIC: ANIMAL BIOTECHNOLOGY MARKET, BY TECHNOLOGY, 2025–2030 (USD MILLION)
TABLE 262 ASIA PACIFIC: ANIMAL BIOTECHNOLOGY MARKET, BY APPLICATION, 2020–2024 (USD MILLION)
TABLE 263 ASIA PACIFIC: ANIMAL BIOTECHNOLOGY MARKET, BY APPLICATION, 2025–2030 (USD MILLION)
TABLE 264 ASIA PACIFIC: MICROBIAL BIOTECHNOLOGY MARKET, BY COUNTRY, 2020–2024 (USD MILLION)
TABLE 265 ASIA PACIFIC: MICROBIAL BIOTECHNOLOGY MARKET, BY COUNTRY, 2025–2030 (USD MILLION)
TABLE 266 ASIA PACIFIC: MICROBIAL BIOTECHNOLOGY MARKET, BY TYPE, 2020–2024 (USD MILLION)
TABLE 267 ASIA PACIFIC: MICROBIAL BIOTECHNOLOGY MARKET, BY TYPE, 2025–2030 (USD MILLION)
TABLE 268 ASIA PACIFIC: MICROBIAL BIOTECHNOLOGY MARKET, BY TYPE, 2020-2024 (THOUSAND METRIC TONS)
TABLE 269 ASIA PACIFIC: MICROBIAL BIOTECHNOLOGY MARKET, BY TYPE, 2025-2030 (THOUSAND METRIC TONS)
TABLE 270 ASIA PACIFIC: MICROBIAL BIOTECHNOLOGY MARKET, BY TECHNOLOGY, 2020–2024 (USD MILLION)
TABLE 271 ASIA PACIFIC: MICROBIAL BIOTECHNOLOGY MARKET, BY TECHNOLOGY, 2025–2030 (USD MILLION)
TABLE 272 ASIA PACIFIC: MICROBIAL BIOTECHNOLOGY MARKET, BY APPLICATION, 2020–2024 (USD MILLION)
TABLE 273 ASIA PACIFIC: MICROBIAL BIOTECHNOLOGY MARKET, BY APPLICATION, 2025–2030 (USD MILLION)
TABLE 274 CHINA: PLANT BIOTECHNOLOGY MARKET, BY TYPE, 2020–2024 (USD MILLION)
TABLE 275 CHINA: PLANT BIOTECHNOLOGY MARKET, BY TYPE, 2025–2030 (USD MILLION)
TABLE 276 CHINA: PLANT BIOTECHNOLOGY MARKET, BY APPLICATION, 2020–2024 (USD MILLION)
TABLE 277 CHINA: PLANT BIOTECHNOLOGY MARKET, BY APPLICATION, 2025–2030 (USD MILLION)
TABLE 278 CHINA: ANIMAL BIOTECHNOLOGY MARKET, BY TYPE, 2020–2024 (USD MILLION)
TABLE 279 CHINA: ANIMAL BIOTECHNOLOGY MARKET, BY TYPE, 2025–2030 (USD MILLION)
TABLE 280 CHINA: ANIMAL BIOTECHNOLOGY MARKET, BY APPLICATION, 2020–2024 (USD MILLION)
TABLE 281 CHINA: ANIMAL BIOTECHNOLOGY MARKET, BY APPLICATION, 2025–2030 (USD MILLION)
TABLE 282 CHINA: MICROBIAL BIOTECHNOLOGY MARKET, BY TYPE, 2020–2024 (USD MILLION)
TABLE 283 CHINA: MICROBIAL BIOTECHNOLOGY MARKET, BY TYPE, 2025–2030 (USD MILLION)
TABLE 284 CHINA: MICROBIAL BIOTECHNOLOGY MARKET, BY APPLICATION, 2020–2024 (USD MILLION)
TABLE 285 CHINA: MICROBIAL BIOTECHNOLOGY MARKET, BY APPLICATION, 2025–2030 (USD MILLION)
TABLE 286 INDIA: PLANT BIOTECHNOLOGY MARKET, BY TYPE, 2020–2024 (USD MILLION)
TABLE 287 INDIA: PLANT BIOTECHNOLOGY MARKET, BY TYPE, 2025–2030 (USD MILLION)
TABLE 288 INDIA: PLANT BIOTECHNOLOGY MARKET, BY APPLICATION, 2020–2024 (USD MILLION)
TABLE 289 INDIA: PLANT BIOTECHNOLOGY MARKET, BY APPLICATION, 2025–2030 (USD MILLION)
TABLE 290 INDIA: ANIMAL BIOTECHNOLOGY MARKET, BY TYPE, 2020–2024 (USD MILLION)
TABLE 291 INDIA: ANIMAL BIOTECHNOLOGY MARKET, BY TYPE, 2025–2030 (USD MILLION)
TABLE 292 INDIA: ANIMAL BIOTECHNOLOGY MARKET, BY APPLICATION, 2020–2024 (USD MILLION)
TABLE 293 INDIA: ANIMAL BIOTECHNOLOGY MARKET, BY APPLICATION, 2025–2030 (USD MILLION)
TABLE 294 INDIA: MICROBIAL BIOTECHNOLOGY MARKET, BY TYPE, 2020–2024 (USD MILLION)
TABLE 295 INDIA: MICROBIAL BIOTECHNOLOGY MARKET, BY TYPE, 2025–2030 (USD MILLION)
TABLE 296 INDIA: MICROBIAL BIOTECHNOLOGY MARKET, BY APPLICATION, 2020–2024 (USD MILLION)
TABLE 297 INDIA: MICROBIAL BIOTECHNOLOGY MARKET, BY APPLICATION, 2025–2030 (USD MILLION)
TABLE 298 JAPAN: PLANT BIOTECHNOLOGY MARKET, BY TYPE, 2020–2024 (USD MILLION)
TABLE 299 JAPAN: PLANT BIOTECHNOLOGY MARKET, BY TYPE, 2025–2030 (USD MILLION)
TABLE 300 JAPAN: PLANT BIOTECHNOLOGY MARKET, BY APPLICATION, 2020–2024 (USD MILLION)
TABLE 301 JAPAN: PLANT BIOTECHNOLOGY MARKET, BY APPLICATION, 2025–2030 (USD MILLION)
TABLE 302 JAPAN: ANIMAL BIOTECHNOLOGY MARKET, BY TYPE, 2020–2024 (USD MILLION)
TABLE 303 JAPAN: ANIMAL BIOTECHNOLOGY MARKET, BY TYPE, 2025–2030 (USD MILLION)
TABLE 304 JAPAN: ANIMAL BIOTECHNOLOGY MARKET, BY APPLICATION, 2020–2024 (USD MILLION)
TABLE 305 JAPAN: ANIMAL BIOTECHNOLOGY MARKET, BY APPLICATION, 2025–2030 (USD MILLION)
TABLE 306 JAPAN: MICROBIAL BIOTECHNOLOGY MARKET, BY TYPE, 2020–2024 (USD MILLION)
TABLE 307 JAPAN: MICROBIAL BIOTECHNOLOGY MARKET, BY TYPE, 2025–2030 (USD MILLION)
TABLE 308 JAPAN: MICROBIAL BIOTECHNOLOGY MARKET, BY APPLICATION, 2020–2024 (USD MILLION)
TABLE 309 JAPAN: MICROBIAL BIOTECHNOLOGY MARKET, BY APPLICATION, 2025–2030 (USD MILLION)
LIST OF FIGURES
FIGURE 1 MARKET SEGMENTATION AND REGIONS COVERED
FIGURE 2 AGRICULTURE BIOTECHNOLOGY MARKET: RESEARCH DESIGN
FIGURE 3 BRIEF OF BOTTOM-UP APPROACH
FIGURE 4 AGRICULTURAL BIOTECHNOLOGY MARKET: BOTTOM-UP APPROACH
FIGURE 5 AGRICULTURAL BIOTECHNOLOGY MARKET: TOP-DOWN APPROACH
FIGURE 6 BRIEF OF TOP-DOWN APPROACH
FIGURE 7 DATA TRIANGULATION
FIGURE 8 AGRICULTURE BIOTECHNOLOGY MARKET, BY TECHNOLOGY, 2025 VS. 2030 (USD MILLION)
FIGURE 9 PLANT BIOTECHNOLOGY MARKET, BY TYPE, 2025 VS. 2030 (USD MILLION)
FIGURE 10 ANIMAL BIOTECHNOLOGY MARKET, BY TECHNOLOGY, 2025 VS. 2030 (USD MILLION)
FIGURE 11 MICROBIAL BIOTECHNOLOGY MARKET, BY APPLICATION, 2025 VS. 2030 (USD MILLION)
FIGURE 12 AGRICULTURE BIOTECHNOLOGY MARKET SHARE, BY REGION
FIGURE 13 ADVANCEMENTS IN GENE EDITING, DIGITAL AGRICULTURE, AND MICROBIAL TECHNOLOGIES TO ACCELERATE GLOBAL AGRICULTURE BIOTECHNOLOGY ADOPTION AND DRIVE SUBSTANTIAL MARKET EXPANSION
FIGURE 14 STRONG BIOTECHNOLOGY ADOPTION ACROSS MAJOR AGRICULTURAL ECONOMIES TO PROPEL REGIONAL GROWTH, WITH ASIA PACIFIC AND EUROPE EMERGING AS SIGNIFICANT FUTURE EXPANSION CENTERS
FIGURE 15 EUROPE’S BIOTECHNOLOGY DEMAND TO INCREASE DUE TO SUSTAINABILITY MANDATES, CROP PROTECTION INNOVATIONS, AND GROWING RELIANCE ON SOIL ENHANCEMENT AND STRESS-TOLERANCE SOLUTIONS
FIGURE 16 DIVERSE REGIONAL INVESTMENTS IN PLANT, ANIMAL, AND MICROBIAL TECHNOLOGIES TO SHAPE GLOBAL MARKET DISTRIBUTION AND STRENGTHEN AGRICULTURAL BIOTECHNOLOGY CAPABILITIES WORLDWIDE
FIGURE 17 RAPID PROGRESS IN FERMENTATION, METAGENOMICS, MOLECULAR SELECTION, AND SYNTHETIC BIOLOGY TO SUPPORT HIGH-GROWTH MICROBIAL BIOTECHNOLOGY APPLICATIONS
FIGURE 18 INCREASING FOCUS ON PRODUCTIVITY, DISEASE RESISTANCE, ADVANCED THERAPEUTICS, AND WELFARE SOLUTIONS TO BROADEN ANIMAL BIOTECHNOLOGY ADOPTION
FIGURE 19 PLANT BIOTECHNOLOGY GROWTH DRIVEN BY INNOVATIONS ENHANCING YIELD, PROTECTION, RESILIENCE, AND NUTRITIONAL QUALITY
FIGURE 20 AGRICULTURE BIOTECHNOLOGY MARKET DYNAMICS
FIGURE 21 ADOPTION OF GEN AI IN AGRICULTURE BIOTECHNOLOGY
FIGURE 22 PORTER’S FIVE FORCES ANALYSIS: AGRICULTURE BIOTECHNOLOGY MARKET
FIGURE 23 GLOBAL POPULATION GROWTH, 1950–2050 (BILLION)
FIGURE 24 GDP GROWTH, 2016–2023 (USD TRILLION)
FIGURE 25 COMPREHENSIVE SUPPLY CHAIN STRUCTURE OF AGRICULTURE BIOTECHNOLOGY MARKET DRIVEN BY CLIMATE-SMART TECHNOLOGIES AND POLICY ALIGNMENT
FIGURE 26 AGRICULTURE BIOTECHNOLOGY MARKET: VALUE CHAIN
FIGURE 27 AGRICULTURE BIOTECHNOLOGY MARKET: ECOSYSTEM ANALYSIS
FIGURE 28 EXPORT VALUE OF AGRICULTURE BIOTECHNOLOGY UNDER HS CODE 382100 FOR KEY COUNTRIES, 2020–2024 (USD THOUSAND)
FIGURE 29 IMPORT VALUE OF AGRICULTURE BIOTECHNOLOGY UNDER HS CODE 382100 FOR KEY COUNTRIES, 2020–2024 (USD THOUSAND)
FIGURE 30 TRENDS/DISRUPTIONS IMPACTING CUSTOMER’S BUSINESS
FIGURE 31 INVESTMENT AND FUNDING SCENARIO, 2020–2025 (USD MILLION)
FIGURE 32 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR AGRICULTURE BIOTECHNOLOGY TYPE
FIGURE 33 KEY BUYING CRITERIA FOR AGRICULTURE BIOTECHNOLOGY MARKET, BY TYPE
FIGURE 34 COMMERCIAL DEPLOYMENT & FUTURE ECOSYSTEM (2032–2035)
FIGURE 35 NUMBER OF PATENTS GRANTED FOR AGRICULTURE BIOTECHNOLOGY MARKET, 2014–2024
FIGURE 36 REGIONAL ANALYSIS OF PATENTS GRANTED FOR AGRICULTURE BIOTECHNOLOGY MARKET, 2014–2024
FIGURE 37 AGRICULTURE BIOTECHNOLOGY MARKET, BY TYPE OF ORGANISM, 2025 VS. 2030 (USD MILLION)
FIGURE 38 PLANT BIOTECHNOLOGY MARKET, BY TYPE, 2025 VS. 2030 (USD MILLION)
FIGURE 39 ANIMAL BIOTECHNOLOGY MARKET, BY TYPE, 2025 VS. 2030 (USD MILLION)
FIGURE 40 MICROBIAL BIOTECHNOLOGY MARKET, BY TYPE, 2025 VS. 2030 (USD MILLION)
FIGURE 41 PLANT BIOTECHNOLOGY MARKET, BY APPLICATION, 2025 VS. 2030 (USD MILLION)
FIGURE 42 ANIMAL BIOTECHNOLOGY MARKET, BY APPLICATION, 2025 VS. 2030 (USD MILLION)
FIGURE 43 MICROBIAL BIOTECHNOLOGY MARKET, BY APPLICATION, 2025 VS. 2030 (USD MILLION)
FIGURE 44 PLANT BIOTECHNOLOGY MARKET, BY TECHNOLOGY, 2025 VS. 2030 (USD MILLION)
FIGURE 45 ANIMAL BIOTECHNOLOGY MARKET, BY TECHNOLOGY, 2025 VS. 2030 (USD MILLION)
FIGURE 46 MICROBIAL BIOTECHNOLOGY MARKET, BY TECHNOLOGY, 2025 VS. 2030 (USD MILLION)
FIGURE 47 INDIA TO BE FASTEST-GROWING COUNTRY IN AGRICULTURE BIOTECHNOLOGY MARKET, 2025–2030
FIGURE 48 NORTH AMERICA: AGRICULTURE BIOTECHNOLOGY MARKET SNAPSHOT
FIGURE 49 ASIA PACIFIC: AGRICULTURE BIOTECHNOLOGY MARKET SNAPSHOT
FIGURE 50 AGRICULTURE PLANT BIOTECHNOLOGY: REVENUE ANALYSIS FOR FIVE KEY PLAYERS, 2022–2024 (USD BILLION)
FIGURE 51 AGRICULTURE ANIMAL BIOTECHNOLOGY: REVENUE ANALYSIS FOR FIVE KEY PLAYERS, 2022–2024 (USD BILLION)
FIGURE 52 AGRICULTURE MICROBIAL BIOTECHNOLOGY: REVENUE ANALYSIS FOR KEY PLAYERS, 2022–2024 (USD BILLION)
FIGURE 53 SHARE OF LEADING COMPANIES IN PLANT BIOTECHNOLOGY MARKET, 2024
FIGURE 54 SHARE OF LEADING COMPANIES IN ANIMAL BIOTECHNOLOGY MARKET, 2024
FIGURE 55 SHARE OF LEADING COMPANIES IN MICROBIAL BIOTECHNOLOGY MARKET, 2024
FIGURE 56 BRAND/PRODUCT COMPARISON, BY APPLICATION
FIGURE 57 COMPANY VALUATION OF KEY AGRICULTURE BIOTECHNOLOGY VENDORS
FIGURE 58 EV/EBITDA OF KEY COMPANIES
FIGURE 59 PLANT BIOTECHNOLOGY MARKET: COMPANY EVALUATION MATRIX (KEY PLAYERS), 2024
FIGURE 60 PLANT BIOTECHNOLOGY MARKET: COMPANY FOOTPRINT
FIGURE 61 ANIMAL BIOTECHNOLOGY MARKET: COMPANY EVALUATION MATRIX (KEY PLAYERS), 2024
FIGURE 62 ANIMAL BIOTECHNOLOGY MARKET: COMPANY FOOTPRINT
FIGURE 63 MICROBIAL BIOTECHNOLOGY MARKET: COMPANY EVALUATION MATRIX (KEY PLAYERS), 2024
FIGURE 64 MICROBIAL BIOTECHNOLOGY MARKET: COMPANY FOOTPRINT
FIGURE 65 BASF SE: COMPANY SNAPSHOT
FIGURE 66 BAYER AG: COMPANY SNAPSHOT
FIGURE 67 CORTEVA AGRISCIENCE: COMPANY SNAPSHOT
FIGURE 68 SYNGENTA: COMPANY SNAPSHOT
FIGURE 69 KWS SAAT SE & CO. KGAA: COMPANY SNAPSHOT
FIGURE 70 UPL: COMPANY SNAPSHOT
FIGURE 71 FMC CORPORATION: COMPANY SNAPSHOT
FIGURE 72 SUMITOMO CHEMICAL CO., LTD.: COMPANY SNAPSHOT
FIGURE 73 NUFARM: COMPANY SNAPSHOT
FIGURE 74 ZOETIS INC.: COMPANY SNAPSHOT
FIGURE 75 ELANCO OR ITS AFFILIATES: COMPANY SNAPSHOT
FIGURE 76 MERCK & CO., INC.: COMPANY SNAPSHOT
FIGURE 77 VIRBAC: COMPANY SNAPSHOT
FIGURE 78 HESTER BIOSCIENCES LIMITED: COMPANY SNAPSHOT
FIGURE 79 GENUS PLC: COMPANY SNAPSHOT
FIGURE 80 BOEHRINGER INGELHEIM INTERNATIONAL GMBH: COMPANY SNAPSHOT
FIGURE 81 NOVONESIS GROUP: COMPANY SNAPSHOT
FIGURE 1 MARKET SEGMENTATION AND REGIONS COVERED
FIGURE 2 AGRICULTURE BIOTECHNOLOGY MARKET: RESEARCH DESIGN
FIGURE 3 BRIEF OF BOTTOM-UP APPROACH
FIGURE 4 AGRICULTURAL BIOTECHNOLOGY MARKET: BOTTOM-UP APPROACH
FIGURE 5 AGRICULTURAL BIOTECHNOLOGY MARKET: TOP-DOWN APPROACH
FIGURE 6 BRIEF OF TOP-DOWN APPROACH
FIGURE 7 DATA TRIANGULATION
FIGURE 8 AGRICULTURE BIOTECHNOLOGY MARKET, BY TECHNOLOGY, 2025 VS. 2030 (USD MILLION)
FIGURE 9 PLANT BIOTECHNOLOGY MARKET, BY TYPE, 2025 VS. 2030 (USD MILLION)
FIGURE 10 ANIMAL BIOTECHNOLOGY MARKET, BY TECHNOLOGY, 2025 VS. 2030 (USD MILLION)
FIGURE 11 MICROBIAL BIOTECHNOLOGY MARKET, BY APPLICATION, 2025 VS. 2030 (USD MILLION)
FIGURE 12 AGRICULTURE BIOTECHNOLOGY MARKET SHARE, BY REGION
FIGURE 13 ADVANCEMENTS IN GENE EDITING, DIGITAL AGRICULTURE, AND MICROBIAL TECHNOLOGIES TO ACCELERATE GLOBAL AGRICULTURE BIOTECHNOLOGY ADOPTION AND DRIVE SUBSTANTIAL MARKET EXPANSION
FIGURE 14 STRONG BIOTECHNOLOGY ADOPTION ACROSS MAJOR AGRICULTURAL ECONOMIES TO PROPEL REGIONAL GROWTH, WITH ASIA PACIFIC AND EUROPE EMERGING AS SIGNIFICANT FUTURE EXPANSION CENTERS
FIGURE 15 EUROPE’S BIOTECHNOLOGY DEMAND TO INCREASE DUE TO SUSTAINABILITY MANDATES, CROP PROTECTION INNOVATIONS, AND GROWING RELIANCE ON SOIL ENHANCEMENT AND STRESS-TOLERANCE SOLUTIONS
FIGURE 16 DIVERSE REGIONAL INVESTMENTS IN PLANT, ANIMAL, AND MICROBIAL TECHNOLOGIES TO SHAPE GLOBAL MARKET DISTRIBUTION AND STRENGTHEN AGRICULTURAL BIOTECHNOLOGY CAPABILITIES WORLDWIDE
FIGURE 17 RAPID PROGRESS IN FERMENTATION, METAGENOMICS, MOLECULAR SELECTION, AND SYNTHETIC BIOLOGY TO SUPPORT HIGH-GROWTH MICROBIAL BIOTECHNOLOGY APPLICATIONS
FIGURE 18 INCREASING FOCUS ON PRODUCTIVITY, DISEASE RESISTANCE, ADVANCED THERAPEUTICS, AND WELFARE SOLUTIONS TO BROADEN ANIMAL BIOTECHNOLOGY ADOPTION
FIGURE 19 PLANT BIOTECHNOLOGY GROWTH DRIVEN BY INNOVATIONS ENHANCING YIELD, PROTECTION, RESILIENCE, AND NUTRITIONAL QUALITY
FIGURE 20 AGRICULTURE BIOTECHNOLOGY MARKET DYNAMICS
FIGURE 21 ADOPTION OF GEN AI IN AGRICULTURE BIOTECHNOLOGY
FIGURE 22 PORTER’S FIVE FORCES ANALYSIS: AGRICULTURE BIOTECHNOLOGY MARKET
FIGURE 23 GLOBAL POPULATION GROWTH, 1950–2050 (BILLION)
FIGURE 24 GDP GROWTH, 2016–2023 (USD TRILLION)
FIGURE 25 COMPREHENSIVE SUPPLY CHAIN STRUCTURE OF AGRICULTURE BIOTECHNOLOGY MARKET DRIVEN BY CLIMATE-SMART TECHNOLOGIES AND POLICY ALIGNMENT
FIGURE 26 AGRICULTURE BIOTECHNOLOGY MARKET: VALUE CHAIN
FIGURE 27 AGRICULTURE BIOTECHNOLOGY MARKET: ECOSYSTEM ANALYSIS
FIGURE 28 EXPORT VALUE OF AGRICULTURE BIOTECHNOLOGY UNDER HS CODE 382100 FOR KEY COUNTRIES, 2020–2024 (USD THOUSAND)
FIGURE 29 IMPORT VALUE OF AGRICULTURE BIOTECHNOLOGY UNDER HS CODE 382100 FOR KEY COUNTRIES, 2020–2024 (USD THOUSAND)
FIGURE 30 TRENDS/DISRUPTIONS IMPACTING CUSTOMER’S BUSINESS
FIGURE 31 INVESTMENT AND FUNDING SCENARIO, 2020–2025 (USD MILLION)
FIGURE 32 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR AGRICULTURE BIOTECHNOLOGY TYPE
FIGURE 33 KEY BUYING CRITERIA FOR AGRICULTURE BIOTECHNOLOGY MARKET, BY TYPE
FIGURE 34 COMMERCIAL DEPLOYMENT & FUTURE ECOSYSTEM (2032–2035)
FIGURE 35 NUMBER OF PATENTS GRANTED FOR AGRICULTURE BIOTECHNOLOGY MARKET, 2014–2024
FIGURE 36 REGIONAL ANALYSIS OF PATENTS GRANTED FOR AGRICULTURE BIOTECHNOLOGY MARKET, 2014–2024
FIGURE 37 AGRICULTURE BIOTECHNOLOGY MARKET, BY TYPE OF ORGANISM, 2025 VS. 2030 (USD MILLION)
FIGURE 38 PLANT BIOTECHNOLOGY MARKET, BY TYPE, 2025 VS. 2030 (USD MILLION)
FIGURE 39 ANIMAL BIOTECHNOLOGY MARKET, BY TYPE, 2025 VS. 2030 (USD MILLION)
FIGURE 40 MICROBIAL BIOTECHNOLOGY MARKET, BY TYPE, 2025 VS. 2030 (USD MILLION)
FIGURE 41 PLANT BIOTECHNOLOGY MARKET, BY APPLICATION, 2025 VS. 2030 (USD MILLION)
FIGURE 42 ANIMAL BIOTECHNOLOGY MARKET, BY APPLICATION, 2025 VS. 2030 (USD MILLION)
FIGURE 43 MICROBIAL BIOTECHNOLOGY MARKET, BY APPLICATION, 2025 VS. 2030 (USD MILLION)
FIGURE 44 PLANT BIOTECHNOLOGY MARKET, BY TECHNOLOGY, 2025 VS. 2030 (USD MILLION)
FIGURE 45 ANIMAL BIOTECHNOLOGY MARKET, BY TECHNOLOGY, 2025 VS. 2030 (USD MILLION)
FIGURE 46 MICROBIAL BIOTECHNOLOGY MARKET, BY TECHNOLOGY, 2025 VS. 2030 (USD MILLION)
FIGURE 47 INDIA TO BE FASTEST-GROWING COUNTRY IN AGRICULTURE BIOTECHNOLOGY MARKET, 2025–2030
FIGURE 48 NORTH AMERICA: AGRICULTURE BIOTECHNOLOGY MARKET SNAPSHOT
FIGURE 49 ASIA PACIFIC: AGRICULTURE BIOTECHNOLOGY MARKET SNAPSHOT
FIGURE 50 AGRICULTURE PLANT BIOTECHNOLOGY: REVENUE ANALYSIS FOR FIVE KEY PLAYERS, 2022–2024 (USD BILLION)
FIGURE 51 AGRICULTURE ANIMAL BIOTECHNOLOGY: REVENUE ANALYSIS FOR FIVE KEY PLAYERS, 2022–2024 (USD BILLION)
FIGURE 52 AGRICULTURE MICROBIAL BIOTECHNOLOGY: REVENUE ANALYSIS FOR KEY PLAYERS, 2022–2024 (USD BILLION)
FIGURE 53 SHARE OF LEADING COMPANIES IN PLANT BIOTECHNOLOGY MARKET, 2024
FIGURE 54 SHARE OF LEADING COMPANIES IN ANIMAL BIOTECHNOLOGY MARKET, 2024
FIGURE 55 SHARE OF LEADING COMPANIES IN MICROBIAL BIOTECHNOLOGY MARKET, 2024
FIGURE 56 BRAND/PRODUCT COMPARISON, BY APPLICATION
FIGURE 57 COMPANY VALUATION OF KEY AGRICULTURE BIOTECHNOLOGY VENDORS
FIGURE 58 EV/EBITDA OF KEY COMPANIES
FIGURE 59 PLANT BIOTECHNOLOGY MARKET: COMPANY EVALUATION MATRIX (KEY PLAYERS), 2024
FIGURE 60 PLANT BIOTECHNOLOGY MARKET: COMPANY FOOTPRINT
FIGURE 61 ANIMAL BIOTECHNOLOGY MARKET: COMPANY EVALUATION MATRIX (KEY PLAYERS), 2024
FIGURE 62 ANIMAL BIOTECHNOLOGY MARKET: COMPANY FOOTPRINT
FIGURE 63 MICROBIAL BIOTECHNOLOGY MARKET: COMPANY EVALUATION MATRIX (KEY PLAYERS), 2024
FIGURE 64 MICROBIAL BIOTECHNOLOGY MARKET: COMPANY FOOTPRINT
FIGURE 65 BASF SE: COMPANY SNAPSHOT
FIGURE 66 BAYER AG: COMPANY SNAPSHOT
FIGURE 67 CORTEVA AGRISCIENCE: COMPANY SNAPSHOT
FIGURE 68 SYNGENTA: COMPANY SNAPSHOT
FIGURE 69 KWS SAAT SE & CO. KGAA: COMPANY SNAPSHOT
FIGURE 70 UPL: COMPANY SNAPSHOT
FIGURE 71 FMC CORPORATION: COMPANY SNAPSHOT
FIGURE 72 SUMITOMO CHEMICAL CO., LTD.: COMPANY SNAPSHOT
FIGURE 73 NUFARM: COMPANY SNAPSHOT
FIGURE 74 ZOETIS INC.: COMPANY SNAPSHOT
FIGURE 75 ELANCO OR ITS AFFILIATES: COMPANY SNAPSHOT
FIGURE 76 MERCK & CO., INC.: COMPANY SNAPSHOT
FIGURE 77 VIRBAC: COMPANY SNAPSHOT
FIGURE 78 HESTER BIOSCIENCES LIMITED: COMPANY SNAPSHOT
FIGURE 79 GENUS PLC: COMPANY SNAPSHOT
FIGURE 80 BOEHRINGER INGELHEIM INTERNATIONAL GMBH: COMPANY SNAPSHOT
FIGURE 81 NOVONESIS GROUP: COMPANY SNAPSHOT
